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ABSTRACT 
The search for antibiotic compounds from the natural environment has been going on for seven decades, ever since 
penicillin entered the market and antibiotic treatments became routine. The evolutionary pressure put on the pathogenic 
microorganisms induced a rapid spreading of naturally occurring resistance genes, leaving only the option of finding new 
antibiotics to treat the resistant pathogens. Microorganisms have been extensively mined for their biosynthetic abilities to 
produce biologically active compounds. To date, more than 23 000 microbial natural products have been discovered. The 
Actinomycetales are ubiquitous bacteria that have been used for antibiotic discovery for more than half a century, and 
over 10 000 natural products have been identified from the order. The genus of Streptomyces is acknowledged as the 
most prolific producer of natural products, but lately, non-Streptomyces species have been on the rise in novel drug 
research. Mainly terrestrial species have been studied, but the marine environment offer just as much, if not more, 
biodiversity to mine for new natural products. In this study, five marine and marine-associated samples were collected 
from south Shetland archipelago and southern Sweden coastal areas. The samples were subjected to seven selective 
treatments of varying chemical or physical nature.  The samples were subsequently incubated on one general and six 
selective agar media of varying compositions of nutrients to enrich mainly for bacteria of more advanced metabolic 
capacity. Bacterial isolates (340 and counting) were recovered from the cultures, and the 16S rDNA of 96 strains was 
sequenced. A phylogenetic tree analysis of 91 sequences identified to the genus or species level was carried out. 
Biological assays were carried out on a few selected isolates, and their antibiotic potential was assessed. One strain 
analyzed by HPLC was found to produce the known antibiotic compound oxydifficidin.   
  
POPULÄRVETENSKAPLIG SAMMANFATTNING 
Antibiotika är ett av de viktigaste medel vi har för att bekämpa infektioner. Tyvärr har våra möjligheter att använda olika 
antibiotika kraftigt begränsats på grund av att mikroorganismerna har utvecklat olika resistensmekanismer vilka också 
sprids mellan olika arter. Resistensspridningen är i dag ett globalt problem vilket lett till att man inom forskningen aktivt 
försöker hitta nya typer av antibiotika. Om nya mediciner och behandlingar mot infektioner inte upptäcks och utvecklas 
riskerar mänskligheten att klockan vrids tillbaka till den pre-antibiotiska eran och att enkla infektioner därmed kan bli 
livshotande.  
Nya antibiotika kan upptäckas och vidareutvecklas med hjälp av flera metoder. Den vanligaste och äldsta metoden är att 
leta i naturen efter mikroorganismer som uppvisar en hämmande aktivitet mot andra mikroorganismer. En alternativ 
metod är att modifiera existerande antibiotika på kemisk väg, och på så sätt skapa olika versioner av en och samma 
substans. Ofta används en kombination av båda metoderna, där man först hittar en naturlig substans som man sedan kan 
modifiera. 
Metoden att leta efter mikroorganismer i naturen har hittills lett till upptäckten av 23 000 aktiva molekyler, och då inte 
bara antibiotika, utan också antivirala läkemedel, anti-cancerläkemedel, insektsmedel, industriella enzymer, etc.  Av 
dessa 23 000 substanser kommer cirka 10 000 från en speciell bakteriegrupp som kallas aktinomyceter. 
Aktinomyceter är bakterier som lever naturligt i alla miljöer över hela världen. De är ekonomiskt betydelsefulla eftersom 
de är exceptionellt duktiga på att producera molekyler som kan användas inom medicin, industri, och jordbruk. Jämfört 
med andra vanligt förekommande bakterier är aktinomyceter mycket komplexa, med en avancerad ämnesomsättning som 
gör dem till troliga producenter av ovanliga ämnen som ofta kan komma till användning. Dessa bakterier beräknas kunna 
producera hundra tusen olika sorters substanser vilket är en av anledningarna till att man aktivt letar efter nya arter av 
aktinomyceter 
Den mest lovande miljön att undersöka idag är haven; de är de största ekosystemen som finns på planeten, och de minst 
utforskade. Forskare letar efter nya bakteriearter i allt från uråldriga glaciärer till heta undervattenskällor i havsbotten, 
och nya mikroorganismer upptäcks därför ideligen.  
I det här forskningsprojektet analyserades sammantaget fem olika prover från fyra platser i två världsdelar: Whaler’s Bay 
på Deception Island och Yankee Harbour på Greenwich Island (Antarktis) samt från Mollösund i Skagerak och Torekov i 
Skälderviken (Sverige). Proven behandlades enligt sju olika kemiska och fysiska metoder och bakterier från proven 
odlades sedan upp på agarplattor med varierande typer och mängd av näringsämnen. Intressanta bakteriekolonier 
isolerades, och genom att sekvensera valda delar av bakteriernas DNA kunde de sorteras in i grupper av redan kända 
bakterier på släkt- eller artnivå. Över 300 bakterieisolat har tagits till vara och nära 100 av dessa har identifierats med 
hjälp av DNA-sekvensering. Vissa bakterieisolat testades även för antibiotisk aktivitet mot mikroorganismer som är 
sjukdomsframkallande hos människor. Hos ett isolat hittades flera aktiva substanser, varav en kunde identifieras som 
oxydifficidin, vilket är en tidigare känd antimikrobiell substans. 
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INTRODUCTION 
80 YEARS OF ANTIBIOTICS 
Antibiotic compounds are the weapons of chemical warfare among microorganisms. It is in the process of evolution that 
these compounds have evolved, allowing the survival of the fittest, or survival of the most prolific producer of toxic 
compounds. The fight for a territory is a reality not only for animals, but for microorganisms as well. The means to do 
this vary among the microbes, from finding an own environmental niche (as in the example of extremophiles) to 
producing secondary metabolites that kill intruders (as in antibiotics). The antibiotic compounds discovered from 
microorganisms revolutionized modern medicine when used as a weapon against bacterial infections. 
Fleming found the first natural antibiotic, penicillin, in 1928. The compound was identified as a bacteriostatic and 
bactericidal secondary metabolite of the fungi Penicillium notatum (Ligon, 2004). The drug entered the market 
approximately ten years later, and redefined the way that infectious diseases were viewed. Penicillin provided a cure for 
bacterial pneumonia and meningitis (Streptococcus pneumoniae), diphtheria (Corynebacterium diphtheriae) and 
gonorrhea (Neisseria gonorrhoeae), among others (Fleming, 1929; Sykes, 2001). Following the discovery of penicillin, 
the researchers studying natural antibiotics begun to uncover more functional compounds from diverse microorganisms. 
The following decades are called the “golden age” of antibiotics. During the 1940’s and 1950’s almost all groups of 
important antibiotics against bacteria were found. These are the macrolides, tetracyclines, cephalosporines, and 
aminoglycosides (Bérdy, 2005). Other compounds discovered were also found to be effective against viruses, parasites, 
or tumors, etc. (Talbot et al., 2006).  
Microbial antibiotics have been in use in medicine since the 1940’s. Antibiotics decreased our vulnerability to common 
bacterial infections that had earlier been death sentences. The following over-use of antibiotics can, therefore, be easily 
understood. Unfortunately, the evolution of pathogenic microbes did not abruptly end, as all microbes carrying 
biosynthetic genes for a certain antibiotic, carry also resistance genes for the same compound; otherwise the organisms 
had not survived the production of their own antibiotics (D’Costa, 2006). 
Continuous exposure to antibiotics led quickly to an increasing spread of such resistance genes among especially 
bacterial pathogens, rendering many antibiotics largely ineffective shortly after entering the market (Bush, 2004; Fenical 
and Jensen, 2006). The horizontal transfer of resistance genes between microbes is thought to be mainly responsible in 
most cases and was hurried on by the increased evolutionary pressure (Maplestone et al., 1992; Stone and Williams, 
1992).  
The genomic changes that cause resistance in pathogens, and the way that these changes spread so quickly, are yet not 
completely understood and this is a serious cause for concern (Liu and Pop, 2009). Cassell and Mekalanos (2001) 
suggested that drug-resistant bacterial pathogens might transfer us back to the pre-antibiotic era; and that is quickly 
becoming a reality. For example, methicillin-resistant Staphylococcus aureus (MRSA) cause nowadays more deaths than 
HIV-infections (Bancroft EA, 2007; Liu and Pop, 2009). The measures taken to decrease the damage caused by drug-
resistant pathogens in the later years have not been effective enough to stop the spread of resistance. The remaining 
alternative is to stay ahead of the pathogens by continuously unearthing new compounds. 
APPROACHES FOR DISCOVERY OF ANTIBIOTIC COMPOUNDS 
The search for antibiotics was carried out in roughly the same manner throughout the 20th century, until the new 
techniques developed in the 1990’s began to take over. The old techniques followed the same pattern: an environmental 
niche was sampled for microorganisms, and the compounds obtained from the isolated microorganisms were tested 
against pathogens. The newly emerged techniques were compiled of more high-tech methods, utilizing combinatorial 
chemistry and high-throughput screening against molecular targets. However, even though high-throughput screening of 
mass-produced combinatorial libraries has been used extensively, the expected increase of marketable compounds never 
came (Baltz, 2008; Newman et al., 2003; Payne et al., 2006). 
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Combinatorial biosynthesis utilizes existing compounds and increases the effectiveness of it by developing novel 
derivatives, or by increasing production yields. Gene inactivation, gene combination, mutasynthesis etc., are effective 
ways to improve compounds, their yields and their activity. Unfortunately, they all require the biosynthetic pathways to 
be previously known and these are not always elucidated  (Floss, 2006; Olano et al., 2008, 2009, 2011). These methods 
are commonly applied by large pharmaceutical companies, however, the more straightforward search for novel natural 
compounds from microorganisms is far from obsolete (Clardy et al., 2006) and is still preferred by many (Henkel et al., 
1999). 
WHOLE-CELL SCREENING OF NATURAL ANTIBIOTICS 
In whole-cell screening the fermentation products of the isolate are tested against live target organisms, and any 
antimicrobial properties can be identified by the rate of growth (or lack of growth) of the target. This strategy allows 
identification of antimicrobials in their physiological context. Also, the strategy eliminates all potentially active 
compounds that cannot function in the live target or enter the target cells (Payne et al., 2006). In target-based screening it 
is instead a biochemical target that the fermentation products are tested against. The targets are enzymes or hormones 
collected from chemical libraries (Baltz, 2008). The target-based screening often allows for a higher throughput, but it is 
the whole-cell screening that directly displays antimicrobial potential by affecting a whole target organism. 
Whole-cell screening was used in the early drug discovery projects: it is simple and effective, but the low throughput has 
made it too slow to be an economical approach for working with larger collections of compounds. High-throughput in 
vitro-screening projects has failed to be the good investments that it was earlier believed to be, as the time and money 
spent is not correlated with the amounts of novel finds (Baltz, 2008; Payne et al., 2006). 
ACTINOMYCETES 
Of the approximately 23 000 microbial antibiotics found today, an estimated number of 10 000 have been isolated from 
the order Actinomycetales (Manivasagan et al., 2013). The actinomycetes are the most important prokaryotes both 
economically and biotechnologically as their ability to produce bioactive compounds is undefeated by any other group of 
organisms. They are the producers of approximately 45% of all discovered active natural products, and the genus 
Streptomyces is the top producer with 80% of the compounds within the actinomycetes to its name (Bérdy, 2005).  
The actinomycetes species vary in morphology, growing as coccoid, rod-coccoid, hyphal form, or different degrees of 
differentiated mycelia (Atlas, 1997). The order was previously assumed to be fungi since only filamentous species had 
then been identified that showed all the characteristics of fungi. Molecular analysis has later grouped the actinomycetes 
with bacteria. Common traits among the actinomycetes are a large genome of up to nine megabases, and high GC content 
However, new studies on freshwater actinomycetes indicates that some instead have a low GC content (Ghai et al., 
2012).  
The actinomycetes are well-documented soil bacteria that used to be considered indigenous only to terrestrial 
environments. The actinomycete species recovered from marine sources were suggested to have come from terrestrial 
spores washed out to sea (Weyland, 1969). It was first in 1984 that a marine actinomycetes species of Rhodococcus 
marinonascene was characterized (Helmke and Weyland, 1984). After a series of studies of actinomycetes from marine 
sediments, the idea that the marine environment is colonized by its own indigenous actinomycetes started to gain 
evidence. Some actinomycetes found in marine sediments showed metabolic activity (Moran et al., 1995), and others 
displayed specific marine adaptation (Jensen et al., 1991). The first obligate marine actinomycete genus to be discovered 
was Salinispora (Mincer et al., 2002, 2005), and the two first sea-water obligate species found were Salinispora 
arenicola and Salinispora tropica (Maldonado et al., 2005a). 
The major genus among the actinomycetes is the Streptomyces; this genus does not only contain many species, but these 
species are also exceptionally talented in secondary metabolite production. Streptomycetes are some of the most complex 
bacteria, and they have been extensively studied in terrestrial environments. The terrestrial Streptomyces species grow 
filamentously and form reproductive aerial branches, where sturdy spores form (Chater and Chandra, 2006; Flärdh and 
Buttner, 2009). The very first antibacterial agent from streptomycetes, streptomycin, was discovered in 1943. Since then, 
about 7600 bioactive secondary metabolites have been identified from Streptomyces. Computerized estimations propose 
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that the genus is capable of producing about 100 000 antibiotic compounds all in all (Mahajan and Balachandran, 2012; 
Watve et al., 2001). This means that only a tiny fraction of the potential natural products from this genus have, yet, been 
identified, which leaves a huge window open for new findings.  
The secondary metabolites of streptomycetes have found industrial applications as antibiotics as well as antifungal, 
antiparasitic, antitumor and immunosuppressive drugs, among others (Schrempf and Dyson, 2011). The molecular 
structures of these compounds are diverse and have usually low toxicity which renders them good candidates for drug 
development (Bérdy, 2005). A range of industrially important enzymes are also produced, as well as enzyme inhibitors 
and insecticides (Goodfellow and Williams, 1986). 
MARINE SOURCES OF NEW BIOCHEMICAL DIVERSITY 
The ocean covers more than 70% of the surface of the earth. It is the least explored environment on the planet, especially 
so when looking at microorganisms. The deep oceans, abysses with depths greater than 2000 m, were considered 
biological deserts until a land-mark study (Grassle and Maciolek, 1992) estimated microbiological diversity in such 
habitats to exceed 10 million species (Bull et al., 2000). That extrapolation of data, the basis of the estimation, has later 
been questioned, but the fact remains that the ocean is a smorgasbord of undiscovered microbial diversity (Bull et al., 
2000; Deming, 1998; Glöckner and Joint, 2010; Joint et al., 2010; Maldonado et al., 2005b). 
The terrestrial environments have, successfully, been sampled for microorganisms with the ability to produce natural 
products for a long time. However, when the terrestrial samples begun to yield mostly rediscoveries, many begun to look 
at the marine environments. The actinomycetes of the sea have been shown to be taxonomically diverse and well 
distributed throughout all to date studied locations (Colquhoun et al., 1998; Magarvey et al., 2004; Weyland, 1969). 
However, one must not make the mistake of thinking that the marine environment is a continuous ecosystem. On the 
contrary, it is a collection of wide ranges of extreme niches, all with their own microbial diversity.  
The oceans cover many ranges of extreme environmental factors. Viable microorganisms have been recovered from 
environments with temperatures ranging from as low as -32°C (Breezee et al., 2004; Cassell and Mekalanos, 2001; Price, 
2000; Price and Sowers, 2004) to the surrounding of deep-sea hydrothermal vents where temperatures approach 400°C 
(Eecke et al., 2012; Gerday et al., 2007; Thornburg et al., 2010). As an example of extreme niches, deep-sea 
hydrothermal vents seem to be barren at the first look. But that hostile environment is home to a wide diversity of 
microorganisms that have acclimatized to the high temperatures, high pressure, and acidity (Gerday et al., 2007; Merkel 
et al., 2012; Tarasov et al., 2005; Valverde et al., 2012; Vetriani et al., 2004). The specialization of the inhabitants has 
also yielded biosynthetic pathways that have just begun to be analyzed. The sampling of bacterial communities of 
extreme niches in marine environments carries great potential to be a major approach for unearthing new natural products 
(Deming, 1998; Maldonado et al., 2005b; Takai and Horikoshi, 1999; Thornburg et al., 2010).  
ON THE SUBJECT OF UNCULTURABLES 
In microbiology there is a phenomenon called ”the great plate count anomaly“, a term coined by Staley and Konopka in 
1985. The phrase describes the fact that, when culturing bacteria, only a fraction of the cells in the original sample are 
recovered in culture. Bacterial cells visible and countable using light microscopy are by several order of magnitudes 
more abundant than the cells counted using the plating method (Staley and Konopka, 1985). This discrepancy had been 
observed much earlier; it was first reported by Razumov in 1932. The bacteria and even other microorganisms that do not 
readily grow on plates are commonly called unculturable. 
The idea that some bacteria are unculturable is today somewhat outdated. The unculturable bacteria are likely to be 
perfectly able to grow in culture if the right conditions are found and their metabolic requirements are met (Button et al., 
1993; Connon and Giovannoni, 2002; Vartoukian et al., 2010; Watve et al., 2000). The problem lies instead in finding 
what the bacteria require for their growth. One successfully applied approach to grow difficult species is to simulate the 
natural environment, from which the species originate. This method allows the bacteria to grow in the complex 
environment that they require without having to identify and recreate the missing parameters in the lab (Gavrish et al., 
2008; Kaeberlein et al., 2002; Polsinelli and Mazza, 1984). 
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EXPERIMENTAL TECHNIQUES: ENRICHMENT AND SELECTION 
There are many ways to increase the yield of actinomycete and even other bacterial isolates from complex samples. The 
specific abilities of the actinomycete species can be used to aid their cultivation. For example, a range of different 
treatments and substrates can be used to weed out the unwanted species in a sample. By modifying the methods to 
specifically select for actinomycete growth, the number of unique isolates retrieved can increase considerably. 
Many actinomycete species form sturdy spores when facing difficult environments, this trait can be utilized in sample 
enrichment. Heat-treating the samples or exposing the material to other stress factors can initiate such sporulation. A 
harsh enough treatment would kill the unwanted organisms in the sample, rendering mostly the viable spores to 
germinate and form colonies (Terahara et al., 2013; Wakisaka et al., 1982).  
ISOLATING MICROORGANISMS FROM MARINE SAMPLES 
In this study, three marine samples from Whaler’s bay and Yankee Harbour from the South Shetland archipelago in 
Antarctica and two samples from Mollösund (Skagerak) and Torekov (Skälderviken), in Sweden were analyzed for the 
presence of actinomycete species. The samples varied in their biological nature: one sample consisted of sea water, one 
of beach sand, one of mostly penguin guano, one of mussels, and one of macroalgea. The study provided a chance to 
analyze a broad range of bacterial species, from sessile species to species associated with mollusks and plants. 
The five collected samples were processed with a range of physical and chemical treatments in order to enrich for 
actinomycetes. The samples were, afterwards, cultivated on media with varying nutrient sources, e.g. complex carbon 
sources, trace minerals, as well as with and without selective antibiotics against Gram-negative bacteria and fungi. The 
samples were also cultivated in modified actinomycete traps, a kind of diffusion chamber constructed with Millipore 
membranes (Kaeberlein et al., 2002; (Gavrish et al., 2008). Some promising isolates were subsequently sequenced and 
their phylogeny was elucidated. The ability to produce antimicrobial metabolites was estimated for few selected isolates 
by means of the bioassay against selected bacterial and fungal pathogens, some carrying on the resistant genes. 
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MATERIALS AND METHODS 
BIOLOGICAL MATERIAL 
Five samples of various biological natures were collected from marine environments and marine-influenced terrestrial 
locations. Three samples (Y1, W1, and W2) were collected in the South Shetland archipelago (Antarctica) and two (E1 
and T1) in southern coastal areas in Sweden. Additionally, samples Y1 and W1 were collected above water, while the 
samples W2, E1 and T1 were collected from sub-surface locations. Table 1 provides a detailed description of the samples 
as some of the samples were of a complex biological nature. The samples were frozen at -50° C directly upon their 
arrival to the laboratory. No prior treatment was applied at this point. 
 Table 1. Content, amount, and origin of the samples analyzed in this study. 
 
SAMPLE TREATMENTS AND PREPARATION 
Samples Y1, E1, T1, and W1 were subjected to seven diverse treatments of physical, physical and chemical as well as 
mechanical matter (B1 through B7, Table 2). Sample W2 was subjected to treatments B3 through B7 (Table 2). Each 
treatment was carried out using 0.5 g of sample material. Control treatment (Table 2) consisted of each respective sample 
(0.5g frozen material) proceeded without prior treatment and suspended in 4.5 ml SSW (Sea Salt Water; 16.5 g sea salt,  
1 L deionized sterile H2O, a salt solution of approximately half the oceanic salt concentration). . 
Table 2. Treatments of the samples. 
 
  
Sample  Amount Contents Origin 
Y1 15 g Sand, shell fragments, penguin guano, seaweed, etc. Yankee Harbour, Greenwich Island, Antarctica 
E1 >50 g Mytilus edulis, blue mussels Mollösund, Skagerak, Sweden 
T1 >100g Macroalgea (species undetermined) Torekov, Skälderviken, Sweden 
W1 30 g Volcanic black sand, etc. Whalers’ Bay, Deception Island, Antarctica 
W2 25 g Sea water Whalers’ Bay, Deception Island, Antarctica 
Manner of treatment Treatment name Treatment 
 K Control (no treatment) 
Physical B1 Drying in laminar flow bench (LAF) at room temperature (Jensen et al., 2005) 
 B2 
Drying in LAF at room temperature, heat treated at 120°C for 30 min (Bredholt et al., 
2008) 
 B3 Suspended in 4.5 ml SSW, heat treated at 60°C for 10 min (Jensen et al., 2005) 
 B4 Suspended in 4.5 ml SSW, UV-radiation treated for 15 s (Bredholdt et al., 2007) 
 B5 Suspended in 4.5 ml SSW, microwave treated at 80 W for 45 s (Bredholdt et al., 2007) 
Physical and chemical B6 Suspended in 4.5 ml 1.5% phenol, kept at 30°C for 30 min (Bredholt et al., 2008) 
Mechanical B7 
Suspended in 4.5 ml SSW, rotated with 25 glass beads for 30 min at room temperature 
(Maldonado et al., 2008) 
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Following sample treatments were applied: 
• B1 - the frozen sample was transferred to a petri dish. The sample was kept in a laminar flow bench (LAF) for 
drying overnight. The sample was subsequently gently crushed, and the dry material was used for stamping of 
plates (see under Cultivation). The remaining material was suspended in 4.5 ml SSW. 
• B2 – the treatment was carried out as B1. When the sample was completely dry, the glass petri dish was 
transferred to a 120°C heat cabinet for 30 min. The material was subsequently gently crushed and used for 
stamping of plates. The remaining material was suspended in 4.5 ml SSW. 
• B3 - the frozen sample was directly suspended in 4.5 ml SSW in a falcon tube. The sample was incubated in a 
water bath at 60°C for 10 min. 
• B4 and B5 - the frozen samples were first suspended in 4.5 ml SSW, then transferred to petri dishes. In 
treatment B4, the petri dish was exposed to UV-radiation for 15 s. In treatment B5, the petri dish was irradiated 
with microwaves at 80 W for 45 s. 
• B6 - the frozen sample was suspended in 4.5 ml 1.5% phenol in a falcon tube. The sample was subsequently 
incubated at 30°C for 30 min. 
• B7, the sample was suspended in 4.5 ml SSW in a glass tube. Twenty-five glass beads were added to the tube, 
and the tube was kept on a rotator for 30 min.  
After completed treatments, the samples were diluted in SSW by using a standard dilution protocol until a dilution of 10-5 
was reached. The dilutions 10-3 to 10-5 (300 µl) were used to inoculate agar plates with diverse culture media. Suspension 
was spread onto each plate using a bent plastic inoculation loop. The plating was done in duplicates.  
Additionally, the dry material from treatments B1 and B2 were used for inoculation of plates by stamping. The stamping 
was carried out using autoclaved foam plugs. The plugs were pressed into the dry material and the plates were stamped in 
a clockwise direction, creating a slight dilution effect. 
Actinomycete traps were constructed by attaching Millipore membranes to plastic washers (Gavrish et al., 2008; Hirsch 
and Christensen, 1983). Membranes of pore sizes 0.05, 0.2, and 0.4 µm were used. The traps were inoculated with 100 µl 
of sample dilutions 10-1 and 10-2. Subsequently, the traps were filled with 2.5 ml sterile water agar (1.5 % agar, deionized 
H2O) placed on WA plates and incubated at 20°C. 
CULTURE MEDIA AND CULTIVATION 
Seven agar based culture media were used to cultivate samples out of which six media were selective and one was non-
selective general culture medium. The detailed description of media composition is given in Table 3. The selective media 
were supplemented with antibiotics against Gram-negative bacteria and fungi. The antibiotics used were cycloheximidine 
(50 µg/ml), nystatin (50 µg/ml), and nalidixic acid (30 µg/ml). Vitamin supplements (ATCC Vitamin Supplements) 
added to the WA, IM6, IM7, and IM8 consisted of:  folic acid (2 mg/L), pyridoxine hydrochloride (10 mg/L), riboflavin 
(5 mg/L), biotin (2 mg/L), thiamine (5 mg/L), nicotinic acid (5 mg/L), calcium pantothenate (5 mg/L), vitamin B12 (0.1 
mg/L), p-aminobenzoic acid (5 mg/L), thioctic acid (5 mg/L), and monopotassium phosphate (900 mg/L). 
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Table 3. Culture media used for isolating microorganism from the samples.  
 
After plating, all plates were placed in a growth chamber at 20°C. Upcoming bacterial isolates were and are picked up 
continuously in order to obtain a collection of fast and slow growing organisms. 
SELECTION AND PRESERVATION OF ISOLATES 
In general, isolates for preservation were selected based on their morphology, e.g. color, shape of colony, and texture. 
Ability to grow on complex media as well as which specific treatment the colony survived was also taken into account. 
The selected colonies were transferred to NBC (1 g nutrient broth, 1 g casamino acids, 10 g agar, 1 L H2O) and NBC-SW 
(NBC medium supplemented with 33 g sea salt), respectively. NBC-SW plates were, routinely, used to estimate an 
ability of a given strain to grow in the presence of salt.  Two preservation methods were used to maintain purified 
isolates: i) aliquots of pure isolates were frozen in 50 % salt water for following DNA purification; ii) aliquots of isolates 
were frozen in 50 % glycerol for long-time storage at -70°C. 
DNA ANALYSIS 
The DNA was extracted using the Fast DNA SPIN Kit for Soil (MP Biomedicals) according to the manufacturer’s 
description; approximately 200 µl of culture suspension in 50% salt water was used for DNA extraction. The 16S rDNA 
sequence was subsequently PCR-amplified using Fermentas DreamTaq DNA polymerase mix (Thermo Scientific). The 
primers used were 27F (5’- AGAGTTTGATCMTGGCTCAG - 3’) and 1495R (5’- GGTTACCTTGTTACGACTT - 3’) 
(Lane, 1991; Turner et al., 1999). Each PCR reaction contained 12.5 µl DreamTaq (2X), 0.4 µM of forward and reverse 
primer, respectively, 10 ng/µl DNA template, and 12.5 µl distilled H2O giving a total reaction volume of 25 µl. The PCR 
program used was 95°C for 5 min, 30 cycles of 94°C for 40s, 55°C for 40s, 72°C for 80s, ending with 72°C for 7 min, 
and then kept at 4°C.  
Some isolates that did not amplify using the original PCR program with the primer set given above were afterwards 
amplified using the primer sets 27F against 765R (5′ - CTGTTTGCTCCCCACGCTTTC - 3’), and 704F (5′ - 
GTAGCGGTGAAATGCGTAGA - 3’) against 1492R, respectively (Coombs and Franco, 2003).  
The PCR products were visualized using gel electrophoresis (1% agarose with EtBr) with GeneRuler 1 kb Plus DNA 
Ladder (Thermo Scientific) and subsequently purified using QIAquick PCR Purification kit (Qiagen) according to the 
manufacturer’s description.  
Media Antibiotics Composition 
VPB No Vegetable Peptone Broth 10g, Agar 15g, H2O 1L 
WA Yes Agar 15g, H2O 1L, Vitamins 1ml 
SCN Yes 
Starch 10g, Casein 0.3g, K2HPO4 2g, KN03 2g, NaCl 2g, MgSO4x7H2O, 0.05g, CaCO3 0.02g, 
FeSO4 x7H2O 0.01g, Agar 15g, H2O 1L (Küster and Williams, 1964) 
SCN-SW Yes 
Starch 10g, Casein 0.3g, K2HPO4 2g, KN03 2g, NaCl 2g, MgSO4x7H2O, 0.05g, CaCO3 0.02g, 
FeSO4 x7H2O 0.01g, Agar 15g, Sea salt 33g, H2O 1L (Küster and Williams, 1964) 
IM6 Yes 
Glycerol 0.5g, Starch 0.5g, Sodium propionate 0.5g, KN03 0.1g, asparagine 0.1g, casein 0.3g, 
K2HPO4 0.5g, FeSO4 x7H2O 1mg, Agar 18g, Sea salt 16g, H2O 1L, Vitamins 1ml (adapted from 
Bredholt et al., 2008) 
IM7 Yes 
Chitin 2g, K2HPO4 0.5g, FeSO4 x7H2O 1mg, Agar 18g, Sea salt 23g, H2O 1L, Vitamins 1ml 
(adapted from Bredholt et al., 2008) 
IM8 Yes 
Malt extract 1g, Glycerol 1g, Glucose 1g, Peptone 1g, Yeast extract 1g, Agar 18g, Sea salt 16g, 
H2O 1L (adapted from Bredholt et al., 2008) 
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The purified DNA was transferred into two 96-well plates as templates for sequencing (5 µl of appr. 50 ng/µl). The 
forward (27F) and reverse (1492R) primers (5 µl of 10 µM) were added to 48 wells on each plate. The following DNA 
sequencing was done by Macrogen.  
ISOLATE IDENTIFICATION AND PHYLOGENY 
The sequences from the 16S rRNA gene were from both forward (27F) and reverse (1492R) primers, and thus had an 
overlapping center. The chromatograms were firstly analyzed using Chromas software (McCarthy), where unreliable 
parts of sequences were trimmed off. The forward and reverse sequences were assembled using MEGA5.2 (Tamura et 
al., 2011). The full-length sequences were annotated using BLAST (nucleotide BLAST against highly similar sequences) 
(Altschul et al., 1990; Ye et al., 2006). 
An alignment of the complete sequences was constructed using MEGA5.2. After trimming the alignment, it was used to 
construct a phylogenetic tree. The tree was calculated using Maximum Parsimony, with model Tamura-Nei (Tamura and 
Nei, 1993) and bootstrap testing of 5000. The branches with bootstrap support lower than 75% were collapsed. 
BIOLOGICAL ASSAYS 
Biological assays were carried out by using two methods: i) crosswise interaction plate assay and ii) 96-wells microtiter 
plate assay. 
Crosswise interaction assay plates were constructed by inoculating VPB agar plates (15 cm) with rows of eight bacterial 
isolates (5 µl isolate suspended in 50% salt water). The isolates were positioned in rows, so that each isolate come in 
contact with the seven others (Seyedsayamdost et al., 2012). The plates were incubated for about 14 days and observed 
for visible antagonistic activity. 
The ability to produce antimicrobial metabolites of one selected isolate (T74) was analyzed by microtiter plate assay 
(Pohanka et al., 2005). Prior to analysis, the isolate was cultured in 50% Vegetable Peptone Broth (VPB, (Oxoid Ltd), 
15.5 g VPB, 1L deionized H2O) and in modified Mineral Medium (Pohanka et al., 2005; Stanier et al., 1966), both in 
baffled and non-baffled Erlenmayer flasks, (96h, 20°C, 160 rpm). Six to twenty-four hours after inoculation, nylon bags 
with a sterile polymeric resin Amberlite XAD 16 (Sigma-Aldrich; approximately 5g per bag) were submerged to cultures 
in order to collect metabolites produced during culturing. Prior to the use, the polymeric resin was activated as advised 
by manufacturer.  
At the end of cultivation Amberlite bags were removed from the cultures, washed with deionized H2O (approximately 80 
to 100 ml) and extracted with methanol (40 to 80 ml depending on the sample). The solvents were removed by overnight 
drying (30°C, under flow of N2) and dissolved in an appropriate solvent prior to HPLC- analysis. The extracts were 
fractionated using preparative HPLC (C18 column with increasing gradient of acetonitrile), and the fractions were 
transferred to a set of 96-wells microtiter plates. The extracts were bioassayed against several target microbial pathogens 
according to previously described method (Pohanka et al., 2005). Fractions with activity against one or more target 
pathogens were analyzed with the help of LC-MS (Liquid Chromatography-Mass Spectrometry). Active compounds 
were identified by comparison of their molecular weight with molecular weights of known natural products available at a 
range of chemical databases. All chemical analysis was carried at the Department of Chemistry, SLU. 
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RESULTS 
CULTIVATION 
The cultivation yielded so far a broad range of diverse microbial isolates. The amount of colonies, and their morphology, 
varied several log units between samples, treatments, and media composition (data not shown).  Figure 1 shows a 
comparison of colony yields from the sample Y1 after treatments B1 and B3, respectively.  A wide range of colonies 
with divergent morphology appeared after cultivation of the sample Y1B1 on the non-selective VPB agar medium. The 
colonies varied in size and they were more or less fast growing. Colonies from this sample tended to be rich in pigments, 
often dark yellow, orange, or red (Fig. 1a). In contrast, sample Y1B3 that was also cultured on VPB agar displayed more 
pale beige colonies (Fig. 1b). This clearly demonstrates that the different treatments strongly affected the bacterial 
composition of the samples.  
The nutrient composition and availability of the cultivation media strongly affected the outcome of isolation. It could be 
observed that the colonies grown on different media varied in their morphology, even though they were cultivated from 
the same sample and treatment. This effectively demonstrates the selective power of various nutrient sources. Particularly 
the isolates cultivated on non-selective VPB plates differed greatly in morphology when compared to isolates obtained 
from all selective media. 
In Figure 2, a large, watery colony appeared to be utilizing the starch and/or casein in the medium, surrounding itself 
with a clear zone area. The small surrounding colonies appear to utilize the carbon degraded by the large colony, which 
seems to excrete some kind of digestion enzymes.  
A total number of 340 isolates were recovered and purified up to date. A complete table of all preserved isolates is 
enclosed as Appendix 1. Some points considered when choosing isolates were morphology and size of the colony, 
nutrition requirements, and sample treatment, etc. Upon transfer to NBC media with and without sea salt, the sodium 
requirements of the isolates were noted as well, and taken into account when isolates were chosen for further analysis by 
16S rDNA sequencing and fermentation studies, i.e. production or antibiotic compounds. 
The isolation of microorganisms will continue over a period of few more months, in order to select the ones that grow 
slowly and especially these from the selective media.  The data set collected is of a great value for the future work on 
microbial diversity of samples originating from marine environments. The preserved microbial collection will also serve 
as a valuable source in other projects.  
Figure 1. Comparison of the colony morphology of a) sample Y1B1, to b) sample Y1B3, both cultured on the non-selective VPB agar 
plates. 
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Figure 2. Colony morphology of isolates obtained from the sample Y1K cultured on SCN agar plates. A large, watery and irregular 
colony in the left upper corner of the plate has an ability to utilize the starch and/or casein. This is visualized by the clear zone area 
surrounding the colony. 
16S RDNA AMPLIFICATION  
Most isolates were successfully amplified using the primer set 27F and 1492R (Fig. 3a). The modified program (using 
27F against 765R, and 704F against 1492R) was successfully applied on some isolates as well (Fig. 3b). By using both 
primer pairs in the second program, the faulty primer binding site could in a few cases be identified. Such an example 
could be seen in Fig. 3b, where isolate 130 was successfully amplified using primer pair 704F/1492R, but not using 
27F/765R. A few isolates did not amplify with the use of either of the two methods, these isolates were at the time 
omitted from further analysis.  
 
Figure 3. The gel images of 16S rDNA PCR products that did or did not amplify with a) the primer set of 27F/1492R. and b) the 
primer pairs 27F/765R (top) and 704F/1492R (bottom). The numbers are the isolate identification numbers.  
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SEQUENCING 
Out of 96 isolates that were sequenced, 91 yielded good-quality chromatograms. These sequences were used to identify 
isolates to genus and/or species level, if possible. Identification was done with the help of BLAST database (Ye et al., 
2006). The identity of recovered sequences with sequences available in the NCBI database ranged from 98% to 100%. 
However, the best hits in the database were often non-cultivated environmental isolates and the species-determined 
sequences could only be found further down the list. A table with identity of selected isolates is enclosed as Appendix 2. 
ISOLATE IDENTITY 
The DNA sequencing revealed that of the 91 sequences, 34 were of the order Actinomycetales. The most commonly 
occurring species among these were Rhodococcus sp. and Micrococcus sp., but also Arthrobacter sp. and a few others 
were found. Notably, the found actinomycetes were all so called rare-actinomycetes, i.e. non-Streptomyces species.  
In total, 39 out of 91sequences recovered belonged to various species of Gram-negative bacteria was (Fig. 4), while 52 
belonged to the Gram-positive (Fig. 5). 
IDENTITY OF GRAM-NEGATIVE BACTERIA 
Thirty-nine of Gram-negative bacterial isolates belonged mainly to the following genera/species: 
• Chryseobacterium  
• Erythrobacter  
• Hymenobacter 
• Pseudomonas 
• Methylobacterium 
• Granulosicoccus 
• Psychrobacter 
All isolates were selected from the diverged samples/treatments. Figure 4 shows distribution of Gram- negative isolates 
among genera/species in percent of total number of Gram-negative isolates sequenced.  
For example Chryseobacterium and Hymenobacter isolates were obtained from different treatments of the sample Y1. 
Two Erythrobacter species were found in the sample T1, and treatments B4 and B7. Unexpectedly they grew on IM7 and 
SCN media that both contain antibiotics against Gram-negatives bacteria which indicate that these can be resistant to the 
antibiotics used. Two Methylobacterium adhaesivum strains were isolated from Y1B1 on WA. 
Four Pseudomonas species were isolated from the samples Y1 and E1, mostly on non-selective VPB medium, but one 
grew on SCN medium containing antibiotics against Gram-negative bacteria.  
Seventeen Granulosicoccus strains were isolated from sample T1; several of them appeared to be identical clones. All 
isolates grew best on NBC-SW, containing 3.3% sea salt.  
 Five Psychrobacter strains were isolated from samples E1 and T1. The Psychrobacter strain denoted T74 showed signs 
of antibacterial activity and was subsequently tested for production of antimicrobial metabolites. 
 
 
 
 
Figure 4. Distribution of 39 Gram-negative 
isolates among identified genera/species (%). 
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IDENTITY OF GRAM-POSITIVE BACTERIA 
Fifty-two of Gram-positive bacterial isolates belonged mainly to the following orders/genera/species: 
• Bacillales with predominantly various species of Bacillus and Paenibacillus 
• Staphylococcus 
• Actinomycetales with various species of Micrococcus, Rhodococcus, Agreia, Pseudoclavibacter, 
Brevibacterium, Salinibacterium and Mycobacterium 
All isolates were selected from the diverged samples/treatments. Figure 5 shows distribution of Gram- positive isolates 
among genera/species in percent of total number of Gram-positive isolates sequenced.  
Out of 52 sequenced isolates, 17 different isolates from varying samples were found to belong to the order of Bacillales; 
8 isolates could be identified as Bacillus species. 
One Deinococcus strain was isolated from the control Y1 sample cultured on VPB. The closest identity of this specific 
strain in comparison to a described species was 96%, and the identity to uncultured clones was 99%.  
Five Paenibacillus strains were isolated from samples Y1, E1, and T1 cultured on VPB plates. The samples had 
undergone varying treatments; the isolates expressed a typical colony morphology that was pale and flat. 
A total number of 34 sequences belonged to various Actinomycetales. Eleven strains of Micrococcus species were 
isolated from all five samples, and from varying treatments. All but one was isolated from VPB agar plates; the 
remaining one was isolated from IM8. Among the 7 isolated Arthrobacter strains, 6 were isolated from the sample Y1 
while the remaining one was isolated from the sample E1. One of the strains had grown on VPB, two on IM8, and the 
remaining had grown on IM6 media. All 10 Rhodococcus strains were isolated from samples Y1 and W1. Two were 
isolated from IM6, and remaining once from VPB medium.  
The remaining actinomycete species found were two Agreia species, one Pseudoclavibacter species, one Brevibacterium 
species, one Salinibacterium species, and one Mycobacterium neglectum. They were isolated from samples Y1, T1, and 
E1, and grown on IM7, IM8, and VPB media. 
 
Figure 5. Distribution of 52 Gram-positive isolates among identified genera/species (%).  
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PHYLOGENETIC ANALYSIS   
A broad range of isolates belonging to diverse bacterial species were isolated and identified in this study. A complete 
phylogenetic tree constructed with the use of 88 full-length 16S sequences of isolates recovered during this study is 
shown in Figure 6. Figure 7 shows a separate tree constructed for the branch of all isolates of Actinomycetes.   
Figure 6. A phylogenetic tree of based on 88 sequences of isolates recovered in this study and constructed using the Maximum 
Likelihood analysis. Substitution model Tamura-Nei was used with 5000 bootstrap replicates. The branches with bootstrap support 
below 75% were collapsed. Six type strains included in analysis are marked with their accession numbers. The branch labels describe 
isolate number and identity at the genus or species level.   
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Figure 7. A phylogenetic tree of 34 Actinomycetes recovered in this study based on comparison of their 16 S-rDNA sequences. Two 
type strains of Micrococcus and Rhodococcus are marked with their accession numbers. All branches with bootstrap support lower 
than 75% are omitted. 
 
Figure 8. The crosswise interaction assay plates, with 8 isolates tested against each other. The extensive growth of one Bacillus isolate 
is controlled by some tested isolates, what is visualized by appearance of clearing zone areas around bacterial colonies. 
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BIOLOGICAL ASSAYS 
Both the crosswise interaction assay and microtiter plate assay showed that some of recovered isolates have a potential to 
produce antimicrobial metabolites.  
The crosswise interaction assay plates (Fig. 8) were quickly over-grown by an aggressive isolate of the Bacillus species. 
However, some other isolates managed to fend off the Bacillus and created clearing zones surrounding their colonies. 
The isolates might have a potential to produce metabolites active against Gram-positive bacteria. 
The antimicrobial activity of the isolate 74, of a Psychrobacter species, against several pathogenic microorganisms 
indicated that the isolate produced compounds with antibiotic properties. The isolate inhibited growth of several 
pathogens, but its activity depended on the tested pathogen. The HPLC chromatogram (Fig. 10) shows several different 
areas of activity suggesting that the isolate produces several antimicrobial molecules. The active compound 
corresponding to at least one peak could be identified by its molecular weight. The compound was traced to be 
oxydifficidin,  a known substance with antimicrobial activity (Zimmerman et al., 1987). The position of oxydifficidin is 
arrow-marked in Fig. 10. Corresponding antimicrobial activity is shown below the chromatogram. 
Figure 10. The HPLC chromatogram over a range of metabolites produced by the isolate T74 is shown coupled to the activity against 
eight pathogens. The antimicrobial activity detected after 24 hours and 4 days of incubation is shown below the HPLC chromatogram. 
The red boxes indicate complete inhibition of the target organism, whereas dark yellow indicate intermediate inhibition, and light 
yellow some inhibition. The red arrow points to approximately fraction 58 where the antibiotic compound oxydifficidin was detected.  
Test pathogen at 24 h Fraction number
A 1 1 2 3 1 1
B 3 3 3 2 1 1 1 1
C 1 2 3 3 3 3 3 2 1 1 1 1 1 1
D 1 3 2 3 2 1
E 3 3 3 3
F 3 2 1 1 1 1 2 1 2 3 2 1 1 1 3
G 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 2 3 3 2 1 1 1
H 3 3 1 1 1 1
Test pathogen at 4 days
A 2 3 3 3 3 2 2 1 1 1 1 1
B 2 2 1 1 1 2 2
C 1 1 3 3 3 3 3 2 1 1 1 1 1 1 1 1 1
D 1 1 2 3 1 1 1
E 1 2 1 1 1 1 1 2 3 3
F 3 1 1 1 1 2 1 1
G 2 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 3 2 3 2 3 3 3 3 3 2 2 2 2 2 1 1 1 2 3 3 3 1 3 3 1
H 2 3
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59 61 63 65 67 69 71 73 75 77 79 81 83 85 87 89 91 93 95
A2
10
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DISCUSSION 
SAMPLING THE MARINE ENVIRONMENT 
The aim of this study was to isolate strains of actinomycetes from marine samples. The samples were taken from 
Whaler’s bay and Yankee Harbor in Antarctica, as well as from southwestern coastal areas of Sweden. The samples were 
of diverse biological natures, consisting of seawater, beach sand, penguin guano, blue mussels, and macroalgea. The 
diversity of the samples allowed a series of niches to be studied simultaneously; species ranging from planktonic to 
sessile to mollusk- and macroalgea-associated life styles were targeted. The treatments of the samples allowed different 
genera to flourish, as the treatments divided the sensitive species from the insensitive. This could easily be observed as 
the diversity of the colonies decreased as the harshness of the treatments increased.  
All the different treatments of the samples yielded viable colonies with sizes visible to the naked eye, although, in very 
varying amounts. It seems rather obvious that the harsher treatments (e.g. high temperatures, mechanical disruption) 
would yield fewer viable survivors than milder treatments (e.g. quick UV-radiation, low temperatures), and that was 
indeed confirmed in this study. The sturdy cells of the well-acclimatized species are very interesting from the 
biochemical point of view as their survival talents may indicate additional capabilities. The extremophiles of the marine 
environments are thought to hold great potential of new natural products (Hamedi et al., 2013; Wilson and Brimble, 
2009).  
In the attempts to amplify the 16S rRNA gene from the isolates using PCR, it could be noted that some isolates were not 
amplified using the general 16S rDNA primers. As the primers were substituted with two alternative primer pairs, 
fragmenting the 16S rRNA gene into two separate sequences, PCR products from some isolates could be recovered. In 
some cases, only one of the two fragments could be amplified. This indicates a mutation in the primer binding site, 
creating a mismatch that weakens primer binding. As this problem could be noted in such a small-scale study, while 
working with only about 100 isolates, one might stop to consider what the accumulated effect would be when screening 
marine communities. However, the main bias when culturing microbial samples for analysis is the plate-count anomaly, 
the fact that the main part of the microorganisms cannot be easily cultivated with standard procedures (Vartoukian et al., 
2010). The general cultivability of soil microorganism has been estimated to be 0.30% (Amann et al., 1995; Torsvik et 
al., 1990); the marine microorganisms from sediments or sea water have an estimated cultivability as low as 0.25% 
(Amann et al., 1995; Jones, 1977) and 0.001-0.1% (Amann et al., 1995; Ferguson et al., 1984; Kogure et al., 1979, 1980), 
respectively.  The culture-independent methods were developed to avoid this problem, and a much greater diversity can 
indeed be observed by analyzing the microorganisms without the limiting culturing steps (Hugenholtz et al., 1998; 
Wagner et al., 1993; Weisburg et al., 1991). However, if the PCR bias is as relatively common as detected in this study, 
then the diversity of microbial communities might be underestimated. Another explanation of the problems accounted 
during PCR amplification is a large variability of 16S rDNA sequences and copy numbers among various bacterial taxa. 
Analysis based on  sequenced bacterial genomes show that only a few identical 16S  rDNA copies can be detected and 
that sequence diversity is higher with increasing copy number (Větrovský and Baldrian, 2013). This suggests that 
universal primers might not necessarily amplify the 16S rDNA gene in all microorganisms. Highly dissimilar 16S rDNA 
sequences were previously reported (Yap et al., 1999) .  
Of the 96 isolates that were sequenced, 90 yielded good-quality sequences that could be identified against the BLAST 
database. The number of gram-positive isolates was somewhat larger than the number of gram-negatives. Due to the fact 
that many isolates were taken from the non-selective VPB plates, i.e. the control plates, the amount of gram-negatives is 
larger than expected from the selective plates. The growth-rate of the colonies on media containing limited organic 
carbon, low nutrition, and antibiotics was slower; with a longer incubation time, the number of isolates from selective 
plates is likely to increase. Among the slow-growing colonies on selective plates, the majority of isolated bacteria are 
expected to be gram-positive actinobacteria.  
All of the identified actinomycete isolates to date were so called rare actinomycetes, i.e. non-Streptomyces species. These 
isolated actinomycete strains hold potential of novelty as producers of natural products (Lazzarini et al., 2000; Tiwari and 
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Gupta, 2011, 2012). The role of rare actinomycetes as natural product producers has become more and more important in 
the later years. In 1970 only 11 species of rare actinomycetes had been documented as producers of a sum of 50 bioactive 
compounds, whereas in 2005 as many as 50 species had been found to produce a total of 2500 compounds (Bérdy, 2005). 
The rare actinomycetes are recognized as good sources of novel natural products, but to increase the discovery rate of 
these products, optimized methods of isolation (Maldonado et al., 2005b), fermentation (Genilloud et al., 2011), and 
screening (Bérdy, 2005) must be developed. By trying out several different fermentation conditions, previously 
undetected metabolites can be extracted from both old and new actinomycete species (Bode et al., 2002; Genilloud et al., 
2011) . 
The methods of isolation and cultivation that were used in this study were chosen in an attempt to select for rarer 
organisms. Fewer, but rarer, isolates are more suitable to be screened by the version of small-scale whole-cell screening 
mainly used by smaller research groups. By using samples from less-studied ecological niches, the chance of 
encountering novel organisms can be increased, and even more so by pre-treating the samples by various methods. 
Cultivating the samples on selective media containing different sources of organic carbon and varying concentrations of 
nutrients may further increase the chances of isolating organisms that are not usually found using standard laboratory 
culturing (Button et al., 1993; Connon and Giovannoni, 2002) . 
THE SEARCH FOR NEW ANTIBIOTICS  
The antibiotic resistance genes in microorganisms are part of an ancient evolutionary process; they are not something that 
has emerged recently by the use of antibiotics in medicine. However, the use of antibiotics in modern medicine and 
agriculture as well as increased travelling has increased the evolutionary pressure to develop antibiotic resistance and the 
speed of dispersal of these genes. Today, 70 years after the first introduction of antibiotics on the market, infectious 
diseases still are the major cause of death world-wide and account for 13.3 million deaths per year (Selvameenal et al., 
2009). Resistant strains of previously treatable pathogens emerge constantly. The pursuit of new antibiotic compounds 
will be continuing in all foreseeable future unless completely new methods to efficiently control the presence and/or 
growth of microorganisms are invented.  
Most probably, the outlook for environmental niches to sample for novel microbial metabolites and the use of 
combinatorial biosynthesis will be used side by side in future research. Both techniques have their pros and cons to be 
considered. Combinatorial biosynthesis requires good background libraries, and advanced know-how of both biological 
and chemical nature. When those criteria are met, the work that has to be done is basically an attempt to outsmart 
millions of years of evolution. Seen in that light, it is a miracle that this has actually been done, creating novel molecules 
able to combat pathogens. The synthetic and semisynthetic antibiotics also carry an extra positive: the resistance against 
synthetic drugs is not already common in the environment, and this may lead to a somewhat slower dispersal of 
resistance among targeted pathogens (D’Costa, 2006). The rediscovery rate of natural products antibiotics when isolating 
microorganisms has been steadily increasing; this in turn decreases the effectiveness of the research and renders such 
studies uneconomical (Fenical et al., 1999). But the microbiome of the planet is vast, and only a fraction of it has been 
explored to date (Cragg and Newman, 2002; Harvey, 2000). By targeting new ecosystems, including extreme 
environments, the chance of isolating novel organisms increases and novel microbes are potential gold mines of 
secondary metabolites and biosynthetic gene diversity. It might not be too bold to think that the quite substantial amount 
of natural products that has been found to date could easily be multiplied by a factor of ten, when considering that we 
have not by far studied all accessible ecosystems. Also, many of the cultivable organisms have the ability to produce 
many more secondary metabolites than previously shown when they are grown under special conditions. By varying 
nutrition and stress factors, as well as growth temperature, some organisms can shift their metabolisms and reveal more 
of their biosynthesis potential (Bode et al., 2002; Higgs et al., 2001).  
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FUTURE PERSPECTIVES 
Further studies of marine environments are essential. The abyssal depths of the oceans are mostly unexplored and are 
likely to harbor a great diversity of microorganisms yet unseen. Methods for culturing and isolating microorganisms need 
to be further developed if we should have any chance to investigate the full diversity of microorganisms and their 
biosynthetic abilities (Huber et al., 1995, 1998). Also, microorganisms from the extreme environments might require the 
development of completely new methods of cultivation. For example, cultivation procedures at high pressure and high 
temperatures may need to be developed and made available for standard laboratory settings (Houghton et al., 2007). On 
the other hand, previous studies suggest that many extreme microbes do not always require extreme culturing settings 
(Pettit, 2011). Genomic studies of uncultivated microbes may in parallel not only identify biosynthetic pathways, but also 
help to uncover metabolic pathways than can reveal what factors are missing for successful isolation. The amount of time 
and energy put into the exploration of the terrestrial part of the planet throughout the last centuries has been substantial. 
Similarly, huge resources will also be needed to explore the oceans, but the rewards can be hoped to be even greater.    
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APPENDIX 
APPENDIX 1 
The table lists all isolates taken to date with their respective descriptions of their morphology. Table includes what sample, treatment, 
and medium the isolate was taken from, as well as the approximate colony age in days. Isolates were transferred to fresh plates of 
either VPB or NBC (with and without sea salt). All incubations were at 20°C. 
From plate: Isolate nr. Medium 1 Temp Time Medium 2 Temp Notes: 
Y1B1 #1 VPB/VPA 20°C 4 d VPB/VPA 20°C Yellow/red, buttery, small, round 
 #9 VPB/VPA 20°C 4 d VPB/VPA 20°C Pinkish, medium size, colony is radiating from sample fragment 
 #10 VPB/VPA 20°C 4 d VPB/VPA 20°C Orange, small, colony is radiating from sample fragment 
 #11 VPB/VPA 20°C 4 d VPB/VPA 20°C Bright pink, tiny colony 
 #15 VPB/VPA 20°C 4 d VPB/VPA 20°C Fungal colony, white in color, large 
Y1K1 #1 VPB/VPA 20°C 5d VPB/VPA 20°C Displays some inhibition behavior towards another, larger, colony. Colony is small and whiteish. 
 #2 VPB/VPA 20°C 5d VPB/VPA 20°C Displays inhibition zone, small and yeasty in color 
 #3 VPB/VPA 20°C 5d VPB/VPA 20°C Displays some inhibition, lemon yellow colony 
Y1K2 #4 VPB/VPA 20°C 5d VPB/VPA 20°C Displays some inhibition, shiny small colony with white/yellow color 
 #5 VPB/VPA 20°C 5d VPB/VPA 20°C Shiny, white, inhibits other colony. Yeasty in colour. 
Y1K3 #6 VPB/VPA 20°C 5d VPB/VPA 20°C Displays inhibition, yeasty in color 
 #7 VPB/VPA 20°C 5d VPB/VPA 20°C Displays inhibition, yeasty in colour, slightly yellow 
 #8 VPB/VPA 20°C 5d VPB/VPA 20°C Displays inhibition, yeasty in colour, whitish 
 #12 VPB/VPA 20°C 5d VPB/VPA 20°C Bright pink, tiny colony 
 #13 VPB/VPA 20°C 5d VPB/VPA 20°C White/pink, medium sized colony, round, opaque 
 #14 VPB/VPA 20°C 5d VPB/VPA 20°C Bright orange, round colony 
From plate: Isolate nr. Medium 1 Temp Time Medium 2 Temp Notes: 
E1Skrap #17 VPB 20°C 2d VPB 20°C Fungi? Weird mycelia/roots. White, matte, large (MYXOBACTERIA) 
E1Skrap #18 VPB 20°C 2d VPB 20°C Bacterial colony, white, shiny 
Y1B1 1 #19 VPB 20°C 5d VPB 20°C Red/pink colony. Might have mycelial growth. Small, shiny. 
Y1B1 2 #20 VPB 20°C 5d VPB 20°C Orange/yellow. Might be inhibiting another colony, streak is probably of both. Small. 
Y1B1 2 #21 VPB 20°C 5d VPB 20°C Pale pink, large. Shiny. Somewhat see-thru. 
From plate: Isolate nr. Medium 1 Temp Time Medium 2 Temp Notes: 
Y1B1 30 SCN 20°C 11 d VPB 20°C Clearing zone area around colony. Colony is large, watery and yellow. 
Y1B1 31 SCN 20°C 11 d VPB 20°C Small yellow colony 
Y1B1 32 SCN 20°C 11 d VPB 20°C Large yellow colony, very watery, and flat. 
Y1B1 33 SCN 20°C 11 d VPB 20°C Isolate #31 uppslammat with small surrounding colony. Probably failed, is an experimental technique. 
Y1B5 34 VPB 20°C 5 d VPB 20°C Filamentous growth pattern, white, large. 
Y1B5 35 VPB 20°C 5d VPB 20°C Filamentous growth pattern, white, small 
Y1B5 36 VPB 20°C 5d VPB 20°C Filamentous growth pattern, white, small 
Y1B2 37 VPB 20°C 11d VPB 20°C Lemon yellow, might be inhibiting other colony. 
Y1B1 38 VPB 20°C 10 d VPB 20°C Orange, might be growing filamentously. 
Y1B1 39 VPB 20°C 10 d VPB 20°C Pale pink, waxy. Colony grows unevely, might be filamentously growing. 
Y1B1 40 VPB 20°C 10 d VPB 20°C Orange, uneven colony. Might be growing filamentously. 
Y1B1 41 VPB 20°C 10 d VPB 20°C Orange, waxy, small colony. Is inhibiting other colony. 
Y1B1 #2 42 VPB 20°C 10 d VPB 20°C Large, filamentous. 
Y1B1 #2 43 VPB 20°C 10 d VPB 20°C Large, filamentous. 
Y1B1 #2 44 VPB 20°C 10 d VPB 20°C Yellow, uneven colony. Might be inhibiting. 
Y1B1 #2 45 VPB 20°C 10 d VPB 20°C Lemon yellow, might be inhibiting. 
Y1B1 #2 46 VPB 20°C 10 d VPB 20°C Tiny, orange colony. Inhibiting other colony. 
Y1B1 #2 47 VPB 20°C 10 d VPB 20°C Yellow/orange colony. Might be growing filamentously. Waxy. Uneven growth. 
Y1B7 48 VPB 20°C 4 d VPB 20°C Large, white. Filamentous. 
Y1B7 49 VPB 20°C 4d VPB 20°C Pink, uneven colony. "Strange" look. 
Y1B7 50 VPB 20°C 4d VPB 20°C Pale, pink, see-through, uneven colony. 
E1B1 52 VPB 20°C 6d VPB 20°C Waxy 
E1B1 53 VPB 20°C 6d VPB 20°C Orange 
E1B1 54 VPB 20°C 6d VPB 20°C Yellow 
Y1B7 55 VPB 20°C 4 d VPB 20°C Pale pink, opaque, waxy, uneven 
Y1B7 56.1 VPB 20°C 4 d VPB 20°C White, filamentous 
Y1B7 56.2 VPB 20°C 4 d VPB 20°C White, filamentous 
Y1B7 57 VPB 20°C 4 d VPB 20°C Pink, filamentous. 
Y1K #3 58 VPB 20°C 12 d VPB 20°C Pink, uneven, filamentous? 
Y1K #3 59 VPB 20°C 12 d VPB 20°C Orange, might be inhibiting 
Y1K #3 60 VPB 20°C 12 d VPB 20°C Orange/yellow 
Y1K #3 61 VPB 20°C 12 d VPB 20°C Yellow, might be inhibiting 
Y1K 62 IM8 20°C 12 d VPB 20°C Pale yellow, migh be inhibiting 
Y1K 63 IM8 20°C 12 d VPB 20°C Yellow, inhibiting 
Y1B4 64 VPB 20°C 4 d VPB 20°C Pale pink, uneven growth, might be filamentous. 
Y1B4 65 VPB 20°C 4 d VPB 20°C Paler pink, uneven growth, might be filamentous. 
Y1K 66 VPB 20°C 12 d VPB 20°C Dark purple, tiny colony. 
Y1K 67 VPB 20°C 12 d VPB 20°C Pale pink/white. Opaque. 
Y1K 68 VPB 20°C 12 d VPB 20°C Pale orange, waxy. 
Y1K 69 VPB 20°C 12 d VPB 20°C Pale orange/red, inhibiting other colony. 
E1 skal 70 VPB 20°C 5d VPB 20°C #17.2 Myxobacter 
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E1 skal 71 VPB  20°C 5d VPB 20°C #18.2 white 
E1K 72 VPB  20°C 7 d VPB 20°C Pink, see-through. Inhibiting. 
E1K 73 VPB  20°C 7d VPB 20°C White, filamentous. 
E1K 74 VPB  20°C 7d VPB 20°C Pale pink, opaque, inhibiting. 
Y1K 75 SCN 4 20°C 12 d VPB 20°C Yellow, watery, large. 
T1B1 76 VPB  20°C 4 d VPB 20°C Pale pink, opaque, uneven colony. Colony radiating from fragment. 
T1B1 77 VPB  20°C 4 d VPB 20°C Myxobacteria? Looks like #70, #17.2 
From plate: Isolate nr. Medium 1 Conc. Temp Time Medium 2 Temp Notes: 
E1B1 1 78 VPB  20°C 7 d MEA 20°C Fungi w/ pink center, green ring around center, white radiating mycelia 
E1B1 1 79 VPB  20°C 7d VPB 20°C Uneven growth, white/pink, starshape in middle of colony 
E1B1 1 80 VPB  20°C 7d VPB 20°C Flat, beige colony, w/ dark spot in middle, uneven growth 
E1B2 81 VPB  20°C 7d VPB 20°C Uneven, pink center (raised), waxy 
E1B2 82 VPB  20°C 7d VPB 20°C Dense raised center, circular surrounding center, radiating uneven hyphae 
E1B2 83 VPB  20°C 7d VPB 20°C Look alike to #82, but more even growth 
E1B2 84 VPB  20°C 7d VPB 20°C Pale orange raised center, see-through radiating even colony 
E1B2 85 VPB  20°C 7d VPB 20°C Pink center (raised), radiating hyphae-looking colony, uneven 
E1B2 86 VPB  20°C 7d VPB 20°C Pink dense colony, uneven edges (might be filamentous) 
E1B5 87 VPB 4  14 NBC +- SW 20°C Small, uneven, opalescent, flat 
T1B3 88 VPB 4  14 NBC +- SW 20°C Small, uneven, see-through 
Y1B1 89 VPB 6  19 NBC +- SW 20°C Bright orange, waxy, slightly uneven 
Y1B1 90 VPB 6  19 NBC +- SW 20°C Light orange, waxy, even 
E1B4 91 VPB 4  9 NBC +- SW 20°C Papery, folded, dry, white 
Y1B2 92 VPB 6  19 NBC +- SW 20°C White/yellow, very small, has friend colony 
T1B1 93 VPB 4  12 NBC +- SW 20°C Pink, uneven colony with raised darker center 
Y1B3 94 VPB 5  12 NBC +- SW 20°C Bubbly bacteria, white stiff (like #35) 
T1B1 95 VPB 6  12 NBC +- SW 20°C Actinomycete-look, murkla, white, soft, raised 
T1B1 96 VPB 6  12 NBC +- SW 20°C Actinomycete-look, murkla, white, soft, raised 
T1B1 97 VPB 4  12 NBC +- SW 20°C Large, beige, excretes liquid 
Y1B3 98 VPB 5  12 NBC +- SW 20°C Light yellow, butter 
Y1K 99 SCN 5  21 NBC +- SW 20°C Yellow, very watery, has clearing zone (metabolism), helps other small colonies grow 
Y1B4 100 VPB 5  13 NBC +- SW 20°C Brown (probably dirty streak) 
Y1B4 101 VPB 6  13 NBC +- SW 20°C Small, pink, uneven 
Y1B4 102 VPB 6  13 NBC +- SW 20°C Orange, medium size, round, with darker orange center 
Y1B6 103 VPB 4  13 NBC +- SW 20°C Bubbly, looks like a flower 
From plate: Isolate nr. Medium 1 Conc. Temp Time Medium 2 Temp Notes: 
T1B2 103 IM6  20°C 14 NBC +- SW 20°C Pastel pink/salmon, radiating from fragment 
T1B2 104 SCN  20°C 14 NBC +- SW 20°C White/yellow, radiating from fragment 
T1B2 105 SCN  20°C 14 NBC +- SW 20°C Salmon pink, radiating from sample 
T1B2 106 SCN  20°C 14 NBC +- SW 20°C Mold? 
T1B2 107 IM8  20°C 14 NBC +- SW 20°C Yellow, uneven, radiating from fragment 
T1B2 108 IM8  20°C 14 NBC +- SW 20°C Salmon pink 
T1B2 109 VPB  20°C 14 NBC +- SW 20°C White colony, circle of exudate 
T1B1 110 IM7  20°C 14 NBC +- SW 20°C Mold, small, radiating from fragment (transfer may be unsuccessful) 
T1B1 111 SCN  20°C 14 NBC +- SW 20°C tiny colony, pale,  (transfer may be unsuccessful) 
T1B1 112 SCN  20°C 14 NBC +- SW 20°C tiny colony, pale  (transfer may be unsuccessful) 
Y1B5 113 VPB 5 20°C 15 NBC +- SW 20°C pink, uneven, opaque, smooth 
Y1B5 114 VPB 4 20°C 15 NBC +- SW 20°C small, beige, inhibiting 
Y1B5 115 VPB 4 20°C 15 NBC +- SW 20°C flat, see-through, even 
Y1B1 116 IM6 5 20°C 20 NBC +- SW 20°C Bright yellow, shiny (major colonies represented on plate) 
Y1B1 117 IM6 5 20°C 20 NBC +- SW 20°C Orange, shiny (major colonies represented on plate) 
Y1B1 118 IM6 5 20°C 20 NBC +- SW 20°C pale yellow (major colonies represented on plate) 
Y1B4 119 IM8 4 20°C 14 NBC +- SW 20°C White/beige (the only white on a yellow-colony plate) 
Y1B6 120 VPB 4 20°C 14 NBC +- SW 20°C bubbly white, single colony,  clean 
Y1B6 121 VPB 4 20°C 14 NBC +- SW 20°C dark beige 
Y1B6 122 VPB 4 20°C 14 NBC +- SW 20°C pale, waxy, flat, beige 
T1B2 123 VPB 4 20°C 13 NBC +- SW 20°C Orange, slightly uneven 
Y1B2 124 IM6  20°C 11 NBC +- SW 20°C Orange, smooth, shiny 
Y1B2 125 IM6  20°C 11 NBC +- SW 20°C Yellow, smooth shiny 
Y1B7 126 VPB 6 20°C 14 NBC +- SW 20°C Yellow, uneven, waxy 
Y1B7 127 VPB 5 20°C 14 NBC +- SW 20°C Waxy, orange 
Y1B7 128 VPB 5 20°C 14 NBC +- SW 20°C Pale pink/red, flat, has exudate ring 
Y1B7 129 VPB 6 20°C 14 NBC +- SW 20°C Tiny, pink, uneven 
Y1B7 130 VPB 6 20°C 14 NBC +- SW 20°C Pale orange, waxy, with raised center 
Y1B7 131 VPB 6 20°C 14 NBC +- SW 20°C Tiny orange, matte, uneven 
Y1B7 132 VPB 6 20°C 14 NBC +- SW 20°C Ruby red, domed, shiny 
Y1B7 133 VPB 5 20°C 14 NBC +- SW 20°C Red, flat, semi-shiny 
Y1B7 134 VPB 5 20°C 14 NBC +- SW 20°C White, mold-like, uneven 
Y1B1 135 VPB 6 20°C 20 NBC +- SW 20°C Orange, might be #89 
From plate: Isolate nr. Medium 1 Conc. Temp Time Medium 2 Temp Notes: 
W1B4 136 VPB 6 20°C 5 NBC +- SW 20°C Yellow colony, smooth, shiny, white center 
W1B4 137 VPB 5 20°C 5 NBC +- SW 20°C Partially yellow, part white. Uneven. Dirty streak? 
W1B4 138 VPB 4 20°C 5 NBC +- SW 20°C Pale, see-through, round, shiny, flat 
E1B6 139 VPB 6 20°C 17 NBC +- SW 20°C Waxy, sharp middle peak, white, large 
E1B6 140 VPB 4 20°C 17 NBC +- SW 20°C large uneven colony -> yellow part 
E1B6 141 VPB 4 20°C 17 NBC +- SW 20°C large uneven colony -> white part 
T1B4 142 VPB 5 20°C 13 NBC +- SW 20°C Tiny, white, uneven (looks actinomycete-like) 
T1B4 143 VPB 5 20°C 13 NBC +- SW 20°C Tiny, white, uneven (looks actinomycete-like) 
T1B4 144 VPB 5 20°C 13 NBC +- SW 20°C Tiny, white, uneven (looks actinomycete-like) + creamy 
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T1B4 145 VPB 4 20°C 13 NBC +- SW 20°C Salmon/orange/pink, shiny, even 
T1B4 146 VPB 4 20°C 13 NBC +- SW 20°C Yellow, uneven 
T1B4 147 VPB 4 20°C 13 NBC +- SW 20°C Tiny white, uneven 
T1B4 148 VPB 4 20°C 13 NBC +- SW 20°C Light yellow, opaque 
T1B4 149 VPB 4 20°C 13 NBC +- SW 20°C Tiny white, grows like a pillar, uneven 
T1B4 150 VPB 4 20°C 13 NBC +- SW 20°C Tiny white, grows like a pillar, uneven 
T1B4 151 VPB 4 20°C 13 NBC +- SW 20°C Tiny white, grows like a pillar, uneven 
T1B4 152 VPB 4 20°C 13 NBC +- SW 20°C Tiny white, grows like a pillar, uneven 
T1B4 153 VPB 4 20°C 13 NBC +- SW 20°C Tiny white, grows like a pillar, uneven 
T1B4 154 VPB 5 20°C 13 NBC +- SW 20°C Yellow, slightly uneven, slimy 
T1B4 155 VPB 4 20°C 13 NBC +- SW 20°C Mold, white aerial hyphae 
Y1B1 156 IM8 5 20°C 24 NBC +- SW 20°C Yellow, tiny, uneven 
Y1B1 157 IM8 4 20°C 24 NBC +- SW 20°C Yellow, tiny, uneven 
Y1B1 158 IM8 4 20°C 24 NBC +- SW 20°C Very tiny, yellow 
Y1B1 159 IM8 4 20°C 24 NBC +- SW 20°C Tiny, sandwiched between colonies, might be inhibitory 
Y1B1 160 IM8 4 20°C 24 NBC +- SW 20°C Light yellow 
Y1B1 161 IM8 4 20°C 24 NBC +- SW 20°C Large yellow, a slice of which is darker yellow 
Y1B1 162 IM8 4 20°C 24 NBC +- SW 20°C Pale yellow 
Y1B1 163 IM8 4 20°C 24 NBC +- SW 20°C Small, yellow, might be inhibitory 
E1B4 164 VPB 5 20°C 14 NBC +- SW 20°C Pink, shiny, dome, slightly uneven, slimy 
E1B4 165 VPB 4 20°C 14 NBC +- SW 20°C White with alternating dark rings within, looks inhibiting 
T1K 166 VPB 4 20°C 14 NBC +- SW 20°C Pink, pillar, uneven (mixed colony) 
T1K 167 VPB 4 20°C 14 NBC +- SW 20°C Pink, uneven 
T1K 168 VPB 4 20°C 14 NBC +- SW 20°C Pink, uneven 
Y1B2 169 VPB 4 20°C 24 NBC +- SW 20°C Pink, pillar, uneven, tiny 
Y1B2 170 VPB 4 20°C 24 NBC +- SW 20°C Pink, pillar, uneven, tiny 
W1B6 171 VPB 4 20°C 5 NBC +- SW 20°C Pale, flat, beige 
W1B6 172 VPB 4 20°C 5 NBC +- SW 20°C Pale, flat, beige, waxy 
W1B7 173 VPB 4 20°C 5 NBC +- SW 20°C Orange, tiny 
W1B7 174 VPB 4 20°C 5 NBC +- SW 20°C Pale yellow 
Y1B7 175 IM6 4 20°C 18 NBC +- SW 20°C Yellow, shiny 
Y1B7 176 IM6 5 20°C 18 NBC +- SW 20°C Pale pink, waxy 
E1B3 177 VPB 4 20°C 20 NBC +- SW 20°C Orange, waxy 
E1B7 178 VPB 4 20°C 14 NBC +- SW 20°C Yellow, shiny, uneven 
Y1B7 179 SCN 5 20°C 22 NBC +- SW 20°C Yellow, shiny, round 
Y1B4 180 IM8 5 20°C 22 NBC +- SW 20°C Pale yellow, semi-shiny 
Y1B4 181 SCN 5 20°C 21 NBC +- SW 20°C Yellow, see-through center, seems to digest substrate (has clearing zone) 
T1B1 182 IM8 4 20°C 21 NBC +- SW 20°C Tiny, yellow 
Y1B5 183 IM8 5 20°C 22 NBC +- SW 20°C Yellow, butter-y, murkla, actinomycete-look 
E1K 184 IM8 4 20°C 24 NBC +- SW 20°C Beige, uneven, might be a mixed colony 
T1B1 185 SCN 4 20°C 21 NBC +- SW 20°C Tiny, white/yellow 
E1B1 186 SCN 5 20°C 23 NBC +- SW 20°C Tiny, yellow 
T1B1 187 SCN-SW 4 20°C 21 NBC +- SW 20°C Tiny, bright yellow 
Y1B5 188 VPB 4 20°C 22 NBC +- SW 20°C Beige, tiny, might be inhibitory 
From plate: Isolate nr. Medium 1 Conc. 20°C Time Medium 2 Temp Notes: 
T1B6 189 VPB 5 20°C 17 NBC +- SW 20°C Yellow, large, circular but uneven, ribbed, topped 
T1B6 190 VPB 5 20°C 17 NBC +- SW 20°C Yellow, large, circular but uneven, ribbed, topped 
T1B6 191 VPB 5 20°C 17 NBC +- SW 20°C Yellow, large, circular but uneven, ribbed, topped 
E1K 192 IM6 4 20°C 25 NBC +- SW 20°C Yellow, looks filamentous, fades from center 
E1K 193 IM6 4 20°C 25 NBC +- SW 20°C Pale, uneven 
E1K 194 SCN 4 20°C 25 NBC +- SW 20°C Pale, whitish, uneven 
E1K 195 SCN 4 20°C 25 NBC +- SW 20°C Pale, whitish, uneven 
E1K 196 SCN 4 20°C 25 NBC +- SW 20°C Pale, whitish, uneven 
E1K 197 SCN 4 20°C 25 NBC +- SW 20°C Pale, whitish, uneven 
T1B7 198 SCN 4 20°C 17 NBC +- SW 20°C Yellow, uneven in colour, digests substrate 
T1B7 199 SCN 4 20°C 17 NBC +- SW 20°C White/yellow, round, digests substrate 
T1B7 200 SCN 4 20°C 17 NBC +- SW 20°C Pale orange, waxy, round 
T1B3 201 IM6 4 20°C 21 NBC +- SW 20°C Yellow, shiny 
W1B2 202 VPB 4 20°C 14 NBC +- SW 20°C Waxy, white, smooth 
W1B2 203 VPB 5 20°C 14 NBC +- SW 20°C Yellow, semi-waxy, round 
T1B1 204 SCN  20°C 22 NBC +- SW 20°C Yellow, uneven, grows into plate 
Y1B1 205 VPB 6 20°C 28 NBC +- SW 20°C Large, yellow, uneven, waxy 
Y1B1 206 VPB 6 20°C 28 NBC +- SW 20°C Orange, with darker raised center 
Y1B1 207 VPB 6 20°C 28 NBC +- SW 20°C Orange, with spots, raised center 
Y1B4 208 VPB 6 20°C 22 NBC +- SW 20°C Orange, murkla, uneven, raised 
Y1B4 209 VPB 6 20°C 22 NBC +- SW 20°C Orange, murkla, uneven, raised 
T1B7 210 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 211 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 212 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 213 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 214 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 215 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 216 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 217 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 218 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 219 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 220 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
T1B7 221 VPB 4 20°C 23 NBC +- SW 20°C Tiny white murkla, raised 
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T1B7 222 VPB 5 20°C 23 NBC +- SW 20°C White, small, uneven 
T1B7 223 VPB 5 20°C 23 NBC +- SW 20°C White, small, uneven 
T1B7 224 VPB 5 20°C 23 NBC +- SW 20°C White, small, uneven 
T1B7 225 VPB 5 20°C 23 NBC +- SW 20°C White, small, uneven 
T1B7 226 VPB 5 20°C 23 NBC +- SW 20°C White, small, uneven 
T1B7 227 VPB 5 20°C 23 NBC +- SW 20°C White/yellow, uneven 
TIB5 228 VPB 5 20°C 23 NBC +- SW 20°C Weird, two-plane colony, previous contamination? 
TIB5 229 VPB 4 20°C 23 NBC +- SW 20°C Tydlig vit/beige murkla 
TIB5 230 VPB 4 20°C 23 NBC +- SW 20°C Tydlig vit/beige murkla 
TIB5 231 VPB 4 20°C 23 NBC +- SW 20°C Tydlig vit/beige murkla 
TIB5 232 VPB 4 20°C 23 NBC +- SW 20°C Tydlig vit/beige murkla 
From plate: Isolate nr. Medium 1 Conc. Temp Time Medium 2 Temp Notes: 
W2B3 233 VPB 5 20°C 14 NBC +- SW 20°C Yellow, waxy, topped, round 
W2B4 234 VPB 4 20°C 14 NBC +- SW 20°C Beige, very uneven, excretes (mixed streak) 
W2B4 234.1   20°C 14 NBC +- SW 20°C Beige/white 
W2B4 234.2   20°C 14 NBC +- SW 20°C Beige/white 
W2B4 235 VPB 4 20°C 14 NBC +- SW 20°C Contamination? Colony grows under agar. 
T1B3 236 VPB 4 20°C 25 NBC +- SW 20°C Pale, uneven, "bubbly" 
T1B3 237 VPB 4 20°C 25 NBC +- SW 20°C Pale, uneven, "bubbly" 
T1B3 238 VPB 4 20°C 25 NBC +- SW 20°C Pale, uneven, "bubbly" 
T1B3 239 VPB 4 20°C 25 NBC +- SW 20°C Pale, uneven, "bubbly" 
T1B3 240 VPB 4 20°C 25 NBC +- SW 20°C Large, yellow, slightly raised, with raised spots 
T1B3 241 VPB 4 20°C 25 NBC +- SW 20°C Large, uneven, flat, beige, exudate (digests substrate) 
T1B3 242 VPB 4 20°C 25 NBC +- SW 20°C Like #241, but small and less uneven 
T1B3 243 VPB 4 20°C 25 NBC +- SW 20°C Like #236 
T1B3 244 VPB 4 20°C 25 NBC +- SW 20°C Like #236 
W1B3 245 VPB 4 20°C 12 NBC +- SW 20°C Pale, uneven, grows inside other colony 
W1B3 246 VPB 4 20°C 12 NBC +- SW 20°C Pale, beige, might be inhibitory, round 
W1B5 247 VPB 4 20°C 13 NBC +- SW 20°C Beige, see-through edges, rough center 
W1B5 248 VPB 4 20°C 13 NBC +- SW 20°C Beige, opalescent in circles 
E1B4 249 VPB 4 20°C 22 NBC +- SW 20°C Small, uneven, pale/whitish 
T1K 250 VPB 4 20°C 22 NBC +- SW 20°C Small, uneven, yellow 
T1K 251 VPB 4 20°C 22 NBC +- SW 20°C Small, uneven, white 
Y1B3 252 VPB 4 20°C 26 NBC +- SW 20°C Beige, small, might be inhibitory, darker center 
Y1B3 253 VPB 4 20°C 26 NBC +- SW 20°C White, uneven, leathery 
Y1B3 254 VPB 4 20°C 26 NBC +- SW 20°C Ruby red, semi-shiny, domed 
Y1B3 255 VPB 5 20°C 26 NBC +- SW 20°C Orange, round, shiny 
E1B5 256 IM6 4 20°C 27 NBC +- SW 20°C Tiny, yellow 
Y1B6 257 VPB 4 20°C 27 NBC +- SW 20°C Pale, leathery, uneven 
E1B7 258 VPB 4 20°C 24 NBC +- SW 20°C Pale, uneven, rough center 
E1B7 259 VPB 4 20°C 24 NBC +- SW 20°C Pale, beige, shiny, domed 
E1B7 260 VPB 5 20°C 24 NBC +- SW 20°C Beige, waxy, large, topped 
E1B7 261 VPB 5 20°C 24 NBC +- SW 20°C   -||-  beige part 
E1B7 262 VPB 5 20°C 24 NBC +- SW 20°C   -||-  white  part 
Y1B2 263 VPB 4 20°C 33 NBC +- SW 20°C Orange, rough, uneven 
Y1B2 264 VPB 4 20°C 33 NBC +- SW 20°C Orange, watery, grainy 
W2B6 265 VPB 4 20°C 15 NBC +- SW 20°C Sunflower! Light yellow, round, ribbed 
W2B6 266 VPB 4 20°C 15 NBC +- SW 20°C Pale yellow/yellow, smooth, round, topped 
W2B6 267 VPB 4 20°C 15 NBC +- SW 20°C Pale yellow/yellow, shiny, round, domed 
W2B6 268 VPB 4 20°C 15 NBC +- SW 20°C White, rough surface, round, creamy 
Y1B7 269 IM7 4 20°C 27 NBC +- SW 20°C Tiny, yellow 
Y1B7 270 IM7 4 20°C 27 NBC +- SW 20°C Tiny, yellow 
Y1B7 271 IM8 4 20°C 27 NBC +- SW 20°C Tiny, yellow 
T1B1 272 VPB 4 20°C 22 NBC +- SW 20°C Small, white, uneven 
T1B1 273 VPB 4 20°C 22 NBC +- SW 20°C Small, white, uneven 
T1B1 274 VPB 4 20°C 22 NBC +- SW 20°C Small, white, uneven 
T1B1 275 VPB 4 20°C 22 NBC +- SW 20°C Small, white, uneven, looks inhibiting 
From plate: Isolate nr. Medium 1 Conc. Temp Time Medium 2 Temp Notes: 
T1B7 276 IM6 4 20°C 24 NBC +- SW 20°C Light yellow, round, waxy 
T1B7 277 IM6 5 20°C 24 NBC +- SW 20°C Bright yellow, shiny 
T1B7 278 IM8 4 20°C 24 NBC +- SW 20°C yellow, small, uneven 
T1B7 279 SCN 5 20°C 24 NBC +- SW 20°C Tiny, orange/red, shiny 
T1B7 280 IM7 4 20°C 24 NBC +- SW 20°C Tiny, red, shiny 
T1B7 281 IM7 4 20°C 24 NBC +- SW 20°C Pale yellow, watery 
Y1B7 282 IM8 5 20°C 29 NBC +- SW 20°C Yellow, waxy, uneven surface, round 
Y1B7 283 IM8 5 20°C 29 NBC +- SW 20°C White, tiny, uneven 
T1B7 284 IM8 5 20°C 24 NBC +- SW 20°C Tiny, yellow 
Y1B1 285 IM6 6 20°C 35 NBC +- SW 20°C Tiny, red, matte 
Y1B1 286 WA 4 20°C 35 NBC +- SW 20°C Tiny, red, shiny 
Y1B1 287 WA 4 20°C 35 NBC +- SW 20°C Pale 
Y1B1 288 WA 4 20°C 35 NBC +- SW 20°C  - 
Y1B1 290 IM8 4 20°C 35 NBC +- SW 20°C Yellow, uneven 
Y1B1 291 IM8 4 20°C 35 NBC +- SW 20°C Yellow, rough surface, uneven, shiny 
Y1B1 292 IM8 4 20°C 35 NBC +- SW 20°C Yellow/orange, uneven 
W1B1 293 VPB 4 20°C 21 NBC +- SW 20°C Orange, waxy, topped 
W2B3 294 VPB 4 20°C 17 NBC +- SW 20°C Microcolony, pale 
T1B1 295 VPB 4 20°C 28 NBC +- SW 20°C Pale yellow, round, waxy 
T1B1 296 VPB 4 20°C 28 NBC +- SW 20°C White, small (beige/pale), with raised white "hat" 
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T1B1 297 VPB 5 20°C 28 NBC +- SW 20°C Yellow, smooth, waxy, round, topped 
T1B1 298 VPB 5 20°C 28 NBC +- SW 20°C White, smooth, waxy, round, topped 
T1B4 299 SCN 4 20°C 24 NBC +- SW 20°C Yellow, see-through, grows into plate like flower petals 
T1B4 300 SCN 4 20°C 24 NBC +- SW 20°C Yellow, see-through, grows into plate like flower petals 
T1B4 301 SCN 4 20°C 24 NBC +- SW 20°C tiny orange/salmon 
T1B4 302 SCN 4 20°C 24 NBC +- SW 20°C Pale, flat 
T1B4 303 SCN 4 20°C 24 NBC +- SW 20°C Pale, flat 
T1B4 304 SCN 4 20°C 24 NBC +- SW 20°C Bright yellow 
T1B4 305 IM8 4 20°C 24 NBC +- SW 20°C Salmon, watery 
T1B4 306 IM8 4 20°C 24 NBC +- SW 20°C Bright yellow, small 
T1B4 307 IM8 4 20°C 24 NBC +- SW 20°C Bright yellow, small 
T1B4 308 IM8 6 20°C 24 NBC +- SW 20°C Bright yellow, small 
Y1B7 309 IM6 5 20°C 29 NBC +- SW 20°C Bright yellow, shiny, round 
Y1B7 310 IM6 5 20°C 29 NBC +- SW 20°C Bright yellow, shiny, round, flat 
Y1B7 311 IM6 5 20°C 29 NBC +- SW 20°C Yellow, shiny, uneven 
Y1B7 312 IM6 6 20°C 29 NBC +- SW 20°C Orange, shiny 
Y1B7 313 IM6 6 20°C 29 NBC +- SW 20°C Yellow, slightly uneven 
Y1B7 314 IM6 4 20°C 29 NBC +- SW 20°C Pale yellow, opaque, shiny, round 
Y1B7 315 IM6 4 20°C 29 NBC +- SW 20°C Salmon, small, shiny, round, opaque 
Y1B3 316 VPB 4 20°C 28 NBC +- SW 20°C Orange, waxy 
Y1B3 317 VPB 4 20°C 28 NBC +- SW 20°C Orange, shiny 
Y1B3 318 VPB 4 20°C 28 NBC +- SW 20°C Orange, waxy 
Y1B3 319 VPB 4 20°C 28 NBC +- SW 20°C Orange, waxy/shiny 
Y1B3 320 VPB 4 20°C 28 NBC +- SW 20°C Red, shiny 
Y1B3 321 VPB 4 20°C 28 NBC +- SW 20°C Red, shiny, see-through 
Y1B3 322 VPB 4 20°C 28 NBC +- SW 20°C Red, shiny, see-through 
Y1B3 323 VPB 4 20°C 28 NBC +- SW 20°C Light yellow, opaque, slightly waxy 
Y1B3 324 VPB 4 20°C 28 NBC +- SW 20°C Waxy, white, round 
Y1B3 325 VPB 5 20°C 28 NBC +- SW 20°C Orange, semi-shiny, opaque 
E1 326 SCN  20°C 32 NBC + SW 20°C 8 streaks from stamping plate, various colonies 
E1 327 IM8  20°C 32 NBC + SW 20°C 8 streaks from stamping plate, various colonies 
E1 328 IM7  20°C 32 NBC + SW 20°C 8 streaks from stamping plate, various colonies 
E1 329 IM6  20°C 32 NBC + SW 20°C 8 streaks from stamping plate, various colonies 
E1 330 WA  20°C 32 NBC + SW 20°C 8 streaks from stamping plate, various colonies 
E1 331 SCN-SW  20°C 32 NBC + SW 20°C 8 streaks from stamping plate, various colonies 
T1B1 332 IM6 4 20°C 29 NBC +- SW 20°C Pale yellow, flat 
T1B1 333 IM6 4 20°C 29 NBC +- SW 20°C Pale, opaque, tiny 
T1B4 334 VPB 6 20°C 24 NBC +- SW 20°C Filaments. Bacillus? 
W2B6 335 VPB 6 20°C 17 NBC +- SW 20°C Pale, tiny, (several streaks) 
E1 336 WA/NBC+SW  20°C 3 NBC +- SW 20°C From 330, salmon, pale, opaque 
E1 337 SCN/NBC+SW  20°C 3 NBC +- SW 20°C From 326, yellow, opaque 
E1 338 SCN-SW/NBC+SW  20°C 3 NBC +- SW 20°C from 331, orange 
E1 339 IM7/NBC+SW  20°C 3 NBC +- SW 20°C from 328, pale salmon, opaque 
E1 340 IM6/NBC+SW  20°C 3 NBC +- SW 20°C from 329, yellow 
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APPENDIX 2. 
The table lists all sequenced isolates, and their closest match in the BLAST database.  
Isolate 
number 
From 
sample Media Identity 
Max 
score 
Total 
score 
Query 
cover E-value 
Max 
identi Accession 
1B1 Y1B1 VPB Chryseobacterium sp. ARS145-11 16S ribosomal RNA gene, partial sequence 2399 2399 100% 0.0 98% JX827616.1 
6 Y1K VPB Pseudomonas sp. B7B 16S ribosomal RNA gene, partial sequence 2579 2579 99% 0.0 99% KC433652.1 
7 Y1K VPB Aranicola sp. NP34 16S ribosomal RNA gene, partial sequence 2462 2462 100% 0.0 99% EU196321.1 
12 Y1K VPB Hymenobacter sp. R-36616 partial 16S rRNA gene, strain R-36616 2460 2460 99% 0.0 99% FR682737.1 
15 Y1B1 VPB Rhodococcus sp. ZS351 16S ribosomal RNA gene, partial sequence 2571 2571 100% 0.0 99% JX428883.1 
20 Y1B1  VPB Sejongia jeonii strain AT1047 16S ribosomal RNA, partial sequence 2374 2374 97% 0.0 99% NR_025810.1 
39 Y1B1 VPB Bacillus sp. SS14.36 16S ribosomal RNA gene, partial sequence 2632 2632 99% 0.0 99% KC160805.1 
44 Y1B1 VPB Carnobacterium sp. NJ-46 16S rRNA gene, strain NJ-46 2571 2571 99% 0.0 99% AM396913.1 
45 Y1B1 VPB Arthrobacter sp. R-36550 partial 16S rRNA gene, strain R-36550 2567 2567 99% 0.0 100% FR682672.1 
46 Y1B1 VPB Rhodococcus sp. ZS351 16S ribosomal RNA gene, partial sequence 2316 2316 100% 0.0 99% JX428883.1 
48 Y1B7 VPB Chryseobacterium sp. ARS145-11 16S ribosomal RNA gene, partial sequence 2398 2398 97% 0.0 99% JX827616.1 
50 Y1B7 VPB Hymenobacter sp. R-36616 partial 16S rRNA gene, strain R-36616 2390 2390 99% 0.0 98% FR682737.1 
51 E1B1 VPB 
Psychrobacter sp. enrichment culture clone B1-3 16S ribosomal RNA gene, partial 
sequence 2564 2564 100% 0.0 99% GU570642.1 
53 E1B1 VPB 
Staphylococcus pasteuri strain M-S-MRS_7 16S ribosomal RNA gene, partial 
sequence 2615 2615 99% 0.0 99% JQ795861.1 
54 E1B1 VPB 
Pseudoclavibacter helvolus strain CJ-G-TSA2 16S ribosomal RNA gene, partial 
sequence 2512 2512 100% 0.0 99% HM584267.1 
56.1 Y1B7 VPB Kaistia sp. 5YN7-3 16S ribosomal RNA gene, partial sequence 2464 2464 100% 0.0 99% EU723082.1 
57 Y1B7 VPB Hymenobacter sp. R-36616 partial 16S rRNA gene, strain R-36616 2440 2440 99% 0.0 99% FR682737.1 
65 Y1B4 VPB Hymenobacter sp. R-36616 partial 16S rRNA gene, strain R-36616 2459 2459 99% 0.0 99% FR682737.1 
66 Y1K VPB Deinococcus sp. R-38476 partial 16S rRNA gene, strain R-38476 2525 2525 99% 0.0 99% FR682757.1 
68 Y1K VPB Rhodococcus yunnanensis partial 16S rRNA gene, strain R-36475 2486 2486 100% 0.0 99% FR682691.1 
74 E1K VPB Psychrobacter sp. KJF9-2 16S ribosomal RNA gene, partial sequence 2597 2790 89% 0.0 100% JQ800140.1 
77 T1B1 VPB Bacillus sp. SG19 16S ribosomal RNA gene, partial sequence 2614 2846 90% 0.0 100% JX402434.1 
79 E1B1 VPB Bacillus pumilus strain AUES82 16S ribosomal RNA gene, partial sequence 2599 2842 90% 0.0 100% HM585067.1 
80 E1B1 VPB Paenibacillus amylolyticus strain MLL-8 16S ribosomal RNA gene, partial sequence 2553 2792 90% 0.0 99% JQ956529.1 
84 E1B2 VPB Pseudomonas sp. L1-8 partial 16S rRNA gene, isolate L1-8 2532 2727 89% 0.0 99% HF536514.1 
86 E1B2 VPB Psychrobacter sp. DY9-2 16S ribosomal RNA gene, partial sequence 2564 2751 89% 0.0 99% AY383045.1 
87 E1B5 VPB 
Paenibacillus amylolyticus strain NRRL NRS-290 16S ribosomal RNA, partial 
sequence 2588 2588 99% 0.0 99% NR_025882.1 
88 T1B3 VPB Paenibacillus sp. MOLA 507 partial 16S rRNA gene, culture collection MOLA:507 2569 2569 100% 0.0 100% AM990732.1 
89 Y1B1 VPB Mycobacterium neglectum gene for 16S rRNA, partial sequence, strain: GMC129 2484 2484 100% 0.0 99% AB741461.1 
90 Y1B1 VPB Rhodococcus yunnanensis partial 16S rRNA gene, strain R-36475 2510 2510 100% 0.0 99% FR682691.1 
91 E1B4 VPB Psychrobacter maritimus strain 3ps 16S ribosomal RNA gene, partial sequence 2562 2562 99% 0.0 99% FJ039851.1 
93 T1B1 VPB Psychrobacter sp. MV2 16S ribosomal RNA gene, partial sequence 2484 2484 100% 0.0 99% HQ610925.1 
94 Y1B3 VPB Bacillus licheniformis strain ZML-1 16S ribosomal RNA gene, partial sequence 2590 2590 100% 0.0 100% KC513425.1 
98 Y1B3 VPB Micrococcus sp. 20.9 KSS partial 16S rRNA gene, strain 20.9 KSS 2532 2532 100% 0.0 100% HE575933.1 
102 Y1B4 VPB Chryseobacterium sp. ARS145-11 16S ribosomal RNA gene, partial sequence 2375 2375 100% 0.0 98% JX827616.1 
114 Y1B5 VPB Bacillus sp. SS9.15 16S ribosomal RNA gene, partial sequence 2457 2457 100% 0.0 98% KC160674.1 
115 Y1B5 VPB Paenibacillus sp. C7 16S ribosomal RNA gene, partial sequence 2455 2455 100% 0.0 98% AY920751.1 
117 Y1B1 IM6 Rhodococcus sp. SS12.38 16S ribosomal RNA gene, partial sequence 1020 1020 100% 0.0 100% KC160926.1 
118 Y1B1 IM6 
Arthrobacter psychrochitiniphilus gene for 16S rRNA, partial sequence, strain: JCM 
13874 2545 2545 100% 0.0 99% AB588633.1 
136 W1B4 VPB Micrococcus sp. 20.9 KSS partial 16S rRNA gene, strain 20.9 KSS 2523 2523 100% 0.0 99% EU071593.1 
138 W1B4 VPB Bacillus sp. SS9.15 16S ribosomal RNA gene, partial sequence 2604 2604 100% 0.0 99% NR_044255.1 
139 E1B6 VPB Micrococcus luteus strain EHFS1_S04Ha 16S ribosomal RNA gene, partial sequence 2540 2540 99% 0.0 100% NR_044255.1 
142 T1B4 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2508 2508 100% 0.0 99% NR_044255.1 
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143 T1B4 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2508 2508 100% 0.0 99% HM563047.1 
144 T1B4 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2529 2529 100% 0.0 99% NR_044255.1 
149 T1B4 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2361 2361 100% 0.0 99% NR_044255.1 
151 T1B4 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2551 2551 100% 0.0 99% NR_044255.1 
163 Y1B1 IM8 Arthrobacter sp. Cr6-08 16S ribosomal RNA gene, partial sequence 2586 2586 99% 0.0 99% GU784867.1 
165 E1B4 VPB Paenibacillus sp. IHB B 3415 16S ribosomal RNA gene, partial sequence 2529 2529 99% 0.0 99% HM563047.1 
183 Y1B5 IM8 Micrococcus sp. LJY5 16S ribosomal RNA gene, partial sequence 2484 2484 100% 0.0 99% EU379020.1 
190 T1B6 VPB Micrococcus sp. A1 partial 16S rRNA gene, strain A1 2226 2226 99% 0.0 99% AM403127.2 
196 E1K SCN Pseudomonas sp. R3.12 16S ribosomal RNA gene, partial sequence 2566 2566 100% 0.0 99% KC433650.1 
203 W1B2 VPB Micrococcus luteus strain EHFS1_S04Ha 16S ribosomal RNA gene, partial sequence 2538 2538 99% 0.0 100% EU071593.1 
210 T1B7 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence  2545 2545 100% 0.0 99% NR_044255.1 
211 T1B7 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2508 2508 100% 0.0 99% NR_044255.1 
213 T1B7 VPB Staphylococcus pasteuri strain F77032 16S ribosomal RNA gene, partial sequence 2538 2538 98% 0.0 99% HQ908742.1 
214 T1B7 VPB Granulosicoccus sp. ZS4-22 16S ribosomal RNA gene, partial sequence 2560 2560 100% 0.0 99% FJ889674.1 
216 T1B7 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2547 2547 100% 0.0 99% NR_044255.1 
218 T1B7 VPB Granulosicoccus sp. ZS4-22 16S ribosomal RNA gene, partial sequence 2547 2547 100% 0.0 99% FJ889674.1 
219 T1B7 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2549 2549 100% 0.0 99% NR_044255.1 
222 T1B7 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2545 2545 100% 0.0 99% NR_044255.1 
225 T1B7 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2551 2551 100% 0.0 99% NR_044255.1 
229 TIB5 VPB Granulosicoccus sp. ZS4-22 16S ribosomal RNA gene, partial sequence 2519 2519 100% 0.0 99% FJ889674.1 
230 TIB5 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2547 2547 100% 0.0 99% NR_044255.1 
231 TIB5 VPB Granulosicoccus antarcticus strain IMCC3135 16S ribosomal RNA, partial sequence 2558 2558 100% 0.0 99% NR_044255.1 
234.1 W2B4 VPB Bacillus subtilis strain TUST019 16S ribosomal RNA gene, partial sequence 2619 2619 100% 0.0 100% KC456633.1 
234.2 W2B4 VPB Bacillus subtilis strain TUST019 16S ribosomal RNA gene, partial sequence 2615 2615 100% 0.0 100% KC456633.1 
240 T1B3 VPB Micrococcus sp. 20.9 KSS partial 16S rRNA gene, strain 20.9 KSS 2551 2551 100% 0.0 100% HE575933.1 
244 T1B3 VPB Virgibacillus halodenitrificans gene for 16S rRNA, partial sequence, strain: NSW13-2 2651 2651 100% 0.0 100% AB697714.1 
263 Y1B2 VPB Rhodococcus luteus partial 16S rRNA gene, isolate 7Y 2549 2549 100% 0.0 99% AJ576249.1 
264 Y1B2 VPB Rhodococcus luteus partial 16S rRNA gene, isolate 7Y 2549 2549 100% 0.0 99% AJ576249.1 
267 W2B6 VPB Micrococcus flavus strain HME8781 16S ribosomal RNA gene, partial sequence 2519 2519 99% 0.0 99% KC134360.1 
268 W2B6 VPB Micrococcus sp. PA-E028 16S ribosomal RNA gene, partial sequence 2553 2553 100% 0.0 99% FJ233852.1 
277 Y1B7 IM7 Agreia sp. CJ-G-R2A4 16S ribosomal RNA gene, partial sequence 2566 2566 100% 0.0 100% HM584293.1 
280 T1B7 IM7 Erythrobacter sp. R14 16S ribosomal RNA gene, partial sequence 2495 2495 100% 0.0 99% EF177676.1 
282 Y1B7 IM8 Arthrobacter sp. Cr6-08 16S ribosomal RNA gene, partial sequence 2551 2551 100% 0.0 99% GU784867.1 
286 Y1B1 WA 
Methylobacterium adhaesivum gene for 16S ribosomal RNA, partial sequence, strain: 
99c 2457 2457 100% 0.0 99% AB698697.1 
288 Y1B1 WA 
Methylobacterium adhaesivum gene for 16S ribosomal RNA, partial sequence, strain: 
21e 2462 2462 100% 0.0 99% AB698702.1 
293 W1B1 VPB Rhodococcus sp. FI 1022 16S ribosomal RNA gene, partial sequence 1452 1452 97% 0.0 99% JQ691546.1 
296 T1B1 VPB Granulosicoccus sp. ZS4-22 16S ribosomal RNA gene, partial sequence 2545 2545 100% 0.0 99% FJ889674.1 
297 T1B1 VPB Micrococcus sp. LJY5 16S ribosomal RNA gene, partial sequence 2555 2555 99% 0.0 99% EU379020.1 
298 T1B1 VPB Micrococcus luteus strain EHFS1_S04Ha 16S ribosomal RNA gene, partial sequence 2540 2540 99% 0.0 100% EU071593.1 
304 T1B4 SCN Erythrobacter sp. PaH2.09b 16S ribosomal RNA gene, partial sequence 2429 2429 99% 0.0 99% GQ391951.1 
306 T1B4 IM8 Salinibacterium sp. KJF1-8 16S ribosomal RNA gene, partial sequence 2571 2571 100% 0.0 100% JQ799993.1 
308 T1B4 IM8 Agreia sp. CJ-G-R2A4 16S ribosomal RNA gene, partial sequence 2566 2566 100% 0.0 100% HM584293.1 
311 Y1B7 IM6 
Arthrobacter psychrochitiniphilus gene for 16S rRNA, partial sequence, strain: JCM 
13874 2588 2588 100% 0.0 99% AB588633.1 
313 Y1B7 IM6 
Arthrobacter psychrochitiniphilus gene for 16S rRNA, partial sequence, strain: JCM 
13874 2579 2579 100% 0.0 99% AB588633.1 
315 Y1B7 IM6 Rhodococcus sp. FI 1030 16S ribosomal RNA gene, partial sequence 1384 1384 98% 0.0 95% JQ691549.1 
318 Y1B3 VPB Rhodococcus sp. ZS351 16S ribosomal RNA gene, partial sequence 2543 2543 100% 0.0 99% JX428883.1 
339 E1 
IM7/NB
C+SW Brevibacterium sp. EP11 partial 16S rRNA gene, strain EP11 2577 2577 100% 0.0 99% AM398220.1 
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340 E1 
IM6/NB
C+SW Arthrobacter rhombi strain F98.3HR69 16S ribosomal RNA, partial sequence 2549 2549 99% 0.0 99% NR_026448.1 
 
 
